Data / Research funding / New York / Sloan-Kettering Inst Can Research
Sloan-Kettering Inst Can Research: 604 NIH awards ($1.1B) and 2 NSF awards ($1.4M), fiscal years 2021 to 2026
Sloan-Kettering Inst Can Research in New York, NY is funded under 604 NIH awards ($1.1B) and 2 NSF awards ($1.4M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- KUKXRCZ6NZC2
- State
- New York
Awards
The 500 largest of 606 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| AI-driven Structure-enabled Antiviral Platform (ASAP) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $89,845,851 | May 16, 2022 | August 31, 2027 | CHODERA, JOHN DAMON | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $69,157,920 | January 20, 1997 | March 31, 2026 | VICKERS, SELWYN M | reporter.nih.gov |
| The Memorial Sloan Kettering Cancer Center SPORE in Leukemia | NIH | National Cancer Institute | 2021 to 2025 | $10,766,802 | August 24, 2021 | June 30, 2026 | ABDEL-WAHAB, OMAR | reporter.nih.gov |
| The Center for Tumor-Immune Systems Biology at MSKCC | NIH | National Cancer Institute | 2022 to 2025 | $10,610,149 | September 16, 2022 | August 31, 2027 | LESLIE, CHRISTINA S | reporter.nih.gov |
| MSK SPORE in Genomic Instability in Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,402,609 | August 13, 2020 | July 31, 2026 | POWELL, SIMON N. | reporter.nih.gov |
| SPORE in Soft Tissue Sarcoma | NIH | National Cancer Institute | 2021 to 2025 | $10,000,743 | September 1, 2018 | August 31, 2029 | SINGER, SAMUEL | reporter.nih.gov |
| Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer. | NIH | National Cancer Institute | 2022 to 2025 | $9,558,240 | September 20, 2022 | August 31, 2027 | O'REILLY, EILEEN MARY | reporter.nih.gov |
| SPORE in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,408,211 | September 14, 2001 | August 31, 2027 | CHEN, YU | reporter.nih.gov |
| Immunobiology of Allogeneic Hematopoietic Cell Transplantation | NIH | National Cancer Institute | 2021 to 2023 | $7,746,369 | September 30, 1997 | June 30, 2025 | SCHEINBERG, DAVID A | reporter.nih.gov |
| 2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach | NIH | National Cancer Institute | 2021 to 2025 | $7,695,238 | September 26, 2008 | August 31, 2029 | GANY, FRANCESCA M | reporter.nih.gov |
| Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,316,442 | August 15, 2022 | May 31, 2027 | HUANGFU, DANWEI | reporter.nih.gov |
| Coordinating center for the NCI small cell lung cancer research consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,127,674 | June 24, 2022 | May 31, 2027 | RUDIN, CHARLES M. | reporter.nih.gov |
| Genomic control of gene regulatory networks governing early human lineage decisions | NIH | National Human Genome Research Institute | 2021 to 2025 | $7,036,239 | August 19, 2021 | May 31, 2026 | HUANGFU, DANWEI | reporter.nih.gov |
| The Impact of DNA Damage Repair Abnormalities in Prostate Cancer | NIH | National Cancer Institute | 2021 to 2024 | $6,736,793 | September 1, 2019 | August 31, 2025 | OFFIT, KENNETH | reporter.nih.gov |
| Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $6,578,630 | March 6, 2019 | February 28, 2026 | AGHAJANIAN, CAROL | reporter.nih.gov |
| Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,798 | August 20, 2021 | May 31, 2027 | LESLIE, CHRISTINA S | reporter.nih.gov |
| Synergistic role of signaling and epigenetics in leukemic transformation | NIH | National Cancer Institute | 2021 to 2025 | $6,322,598 | January 17, 2017 | July 31, 2030 | LEVINE, ROSS L | reporter.nih.gov |
| Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum | NIH | National Institute on Aging | 2021 to 2025 | $5,959,465 | September 15, 2021 | May 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Chaperome networks in Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2025 | $5,927,093 | February 15, 2021 | January 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| The cBioPortal for Cancer Genomics | NIH | National Cancer Institute | 2022 to 2025 | $5,919,979 | September 5, 2022 | August 31, 2027 | SCHULTZ, NIKOLAUS | reporter.nih.gov |
| Annotating Cancer Biology through Non-Invasive Molecular Imaging | NIH | National Cancer Institute | 2021 to 2025 | $5,790,675 | September 4, 2019 | August 31, 2026 | LEWIS, JASON S. | reporter.nih.gov |
| Mechanisms of DNA and RNA Transactions | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,404,920 | May 3, 2018 | April 30, 2028 | SHUMAN, STEWART H | reporter.nih.gov |
| Comparative Modeling of Effective Policies for Colorectal Cancer Control | NIH | National Cancer Institute | 2021 to 2025 | $5,238,594 | July 1, 2025 | August 31, 2026 | ZAUBER, ANN GRAHAM | reporter.nih.gov |
| MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe | NIH | National Cancer Institute | 2022 to 2025 | $5,223,157 | August 1, 2022 | July 31, 2027 | PANAGEAS, KATHERINE S | reporter.nih.gov |
| Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies. | NIH | National Cancer Institute | 2021 to 2025 | $5,214,422 | August 14, 2020 | July 31, 2027 | SCHEINBERG, DAVID A | reporter.nih.gov |
| Novel therapeutic development for small cell lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,214,420 | August 10, 2021 | July 31, 2028 | RUDIN, CHARLES M. | reporter.nih.gov |
| Mechanisms of DNA Replication, Chromosome Compaction, and Chromosome Unlinking | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,189,618 | April 1, 2018 | March 31, 2028 | MARIANS, KENNETH J | reporter.nih.gov |
| The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer | NIH | National Cancer Institute | 2021 to 2025 | $5,182,391 | September 1, 2020 | August 31, 2027 | MASSAGUE, JOAN | reporter.nih.gov |
| SPORE in Bladder Cancer | NIH | National Cancer Institute | 2021 to 2024 | $5,173,656 | August 24, 2018 | July 31, 2025 | ROSENBERG, JONATHAN ERIC | reporter.nih.gov |
| Towards targeting the lymphoma microenvironment | NIH | National Cancer Institute | 2021 to 2025 | $5,082,235 | September 1, 2020 | August 31, 2027 | WENDEL, HANS-GUIDO | reporter.nih.gov |
| Homology-directed repair: BRCA2 and RAD51 paralogs | NIH | National Cancer Institute | 2021 to 2025 | $5,007,139 | August 1, 2020 | July 31, 2027 | JASIN, MARIA | reporter.nih.gov |
| Understanding the molecular mechanisms regulating fungal colonization and disease in the mammalian intestinal niche | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $4,977,820 | April 1, 2024 | March 31, 2029 | HOHL, TOBIAS M | reporter.nih.gov |
| Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer | NIH | National Cancer Institute | 2022 to 2025 | $4,937,681 | May 6, 2022 | April 30, 2027 | SCOTT, JESSICA | reporter.nih.gov |
| [18F]-PU-AD epichaperome PET imaging probe | NIH | National Institute on Aging | 2022 to 2025 | $4,816,476 | June 15, 2022 | May 31, 2027 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Leveraging Observational (Real World) Data to Advance Precision Oncology | NIH | National Cancer Institute | 2024 to 2025 | $4,729,470 | September 3, 2024 | August 31, 2029 | SAWYERS, CHARLES L. | reporter.nih.gov |
| Mechanisms of Ion Channels and Enzymatic Membrane Proteins | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,724,355 | April 1, 2019 | March 31, 2029 | LONG, STEPHEN BARSTOW | reporter.nih.gov |
| Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis | NIH | National Cancer Institute | 2021 to 2022 | $4,687,701 | September 30, 2018 | August 31, 2025 | PE'ER, DANA | reporter.nih.gov |
| ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC) | NIH | National Cancer Institute | 2021 to 2025 | $4,374,283 | March 1, 2025 | February 28, 2026 | LEVINE, ROSS L | reporter.nih.gov |
| Flexible versus Standard Aerobic Training Dosing in Primary Breast Cancer: A Randomized and Response-Adapted Trial | NIH | National Cancer Institute | 2022 to 2025 | $4,082,444 | September 21, 2022 | August 31, 2027 | SCOTT, JESSICA | reporter.nih.gov |
| A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers | NIH | National Cancer Institute | 2021 to 2025 | $4,028,888 | March 3, 2020 | March 31, 2030 | LEE, NANCY Y | reporter.nih.gov |
| Interrogating Complex Methylome Network with Integrated Chemical Biology Tools | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,968,800 | June 1, 2019 | May 31, 2029 | LUO, MINKUI | reporter.nih.gov |
| Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability | NIH | National Cancer Institute | 2021 to 2024 | $3,915,629 | August 1, 2018 | July 31, 2025 | IACOBUZIO-DONAHUE, CHRISTINE A | reporter.nih.gov |
| DNA Damage & DNA Replication: a Complex Relationship | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $3,891,834 | August 1, 2020 | July 31, 2025 | PETRINI, JOHN HJ | reporter.nih.gov |
| Transcriptional control of NK cell metabolism | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,857,510 | February 10, 2021 | January 31, 2026 | SUN, JOSEPH CHAI-YUEN | reporter.nih.gov |
| MSK Paul Calabresi Career Development Award for Clinical Oncology | NIH | National Cancer Institute | 2021 to 2025 | $3,810,556 | September 4, 2015 | August 31, 2030 | POWELL, SIMON N. | reporter.nih.gov |
| Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors | NIH | National Cancer Institute | 2021 to 2025 | $3,652,183 | July 1, 2021 | June 30, 2026 | KUNG, ANDREW L | reporter.nih.gov |
| Regulated cell death and responses to starvation in cancer | NIH | National Cancer Institute | 2022 to 2025 | $3,616,421 | September 9, 2022 | August 31, 2029 | OVERHOLTZER, MICHAEL H. | reporter.nih.gov |
| PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy | NIH | National Cancer Institute | 2021 to 2025 | $3,606,632 | July 1, 2021 | June 30, 2027 | GRIMM, JAN | reporter.nih.gov |
| HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,601,018 | April 9, 2021 | March 31, 2027 | HSU, KATHARINE C | reporter.nih.gov |
| Empathic Communication Skills Training to Reduce Lung Cancer Stigma | NIH | National Cancer Institute | 2021 to 2025 | $3,592,601 | September 9, 2021 | August 31, 2027 | BANERJEE, SMITA | reporter.nih.gov |
| Chromatin architecture regulating trained immunity in antiviral NK cells | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,519,992 | July 25, 2025 | June 30, 2029 | SUN, JOSEPH CHAI-YUEN | reporter.nih.gov |
| Leveraging fructose transport to create a privileged substrate to selectively fuel T cells | NIH | National Cancer Institute | 2021 to 2025 | $3,492,795 | December 11, 2020 | November 30, 2025 | KESHARI, KAYVAN R | reporter.nih.gov |
| Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling | NIH | National Human Genome Research Institute | 2022 to 2025 | $3,456,199 | August 15, 2022 | May 31, 2027 | OFFIT, KENNETH | reporter.nih.gov |
| Improving radiolabeled imaging and targeting of HER2 positive EG cancers using lovastatin | NIH | National Cancer Institute | 2021 to 2025 | $3,432,890 | December 1, 2020 | November 30, 2026 | LEWIS, JASON S. | reporter.nih.gov |
| Targets for Therapy for Carcinomas of the Lung | NIH | National Cancer Institute | 2021 to 2022 | $3,377,426 | July 1, 2007 | August 31, 2024 | KRIS, MARK G. | reporter.nih.gov |
| INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,376,507 | June 6, 2011 | June 30, 2026 | HOHL, TOBIAS M | reporter.nih.gov |
| A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,359,060 | April 1, 2025 | March 31, 2027 | SCOTT, JESSICA | reporter.nih.gov |
| Toward development of senolytic CAR T cells | NIH | National Institute on Aging | 2025 | $3,326,400 | May 15, 2020 | August 31, 2029 | LOWE, SCOTT W. | reporter.nih.gov |
| Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $3,323,920 | August 13, 2021 | July 31, 2026 | OTAZO, RICARDO | reporter.nih.gov |
| Selective interactome vulnerability across the Alzheimer’s disease spectrum | NIH | National Institute on Aging | 2023 to 2025 | $3,289,457 | September 15, 2023 | May 31, 2028 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,203,281 | April 1, 2021 | March 31, 2027 | STUDER, LORENZ P. | reporter.nih.gov |
| Investigating Extrachromosomal DNA (ecDNA) Segregation and Repair in Cancer | NIH | National Cancer Institute | 2025 | $3,201,530 | August 1, 2025 | July 31, 2029 | SFEIR, AGNEL | reporter.nih.gov |
| Isolation, characterization and translational development of glioma stem cells | NIH | National Cancer Institute | 2021 to 2023 | $3,189,696 | February 1, 2017 | January 31, 2025 | PARADA, LUIS FERNANDO | reporter.nih.gov |
| TYK2 Fusions in Lymphoma | NIH | National Cancer Institute | 2025 | $3,111,184 | September 1, 2025 | August 31, 2029 | ELENITOBA-JOHNSON, KOJO S. J. | reporter.nih.gov |
| M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection | NIH | National Cancer Institute | 2022 to 2025 | $3,081,926 | September 1, 2022 | August 31, 2027 | ROTEMBERG, VERONICA MIRIAM | reporter.nih.gov |
| Understanding and targeting MAPK pathway activation in NF1-deficient malignant peripheral nerve sheath tumor (MPNST) | NIH | National Cancer Institute | 2021 to 2025 | $3,076,366 | April 1, 2021 | March 31, 2026 | CHI, PING | reporter.nih.gov |
| Chemical and Physical Mechanisms of Wound Detection | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,076,041 | May 1, 2021 | April 30, 2026 | NIETHAMMER, PHILIPP MICHAEL | reporter.nih.gov |
| Mechanisms and Function of Myonuclear Positioning | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,074,996 | September 1, 2014 | January 31, 2027 | BAYLIES, MARY K | reporter.nih.gov |
| Role of the Cell Death Machinery in a Somatic Autoinflammatory Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,066,524 | August 21, 2025 | July 31, 2029 | GITLIN, ALEXANDER | reporter.nih.gov |
| CD28-KITv CAR T cells with PD-1 dominant negative receptor | NIH | National Cancer Institute | 2024 to 2025 | $3,061,861 | March 1, 2024 | February 28, 2026 | ADUSUMILLI, PRASAD S. | reporter.nih.gov |
| Exploring the Role of Nitrogen Metabolism in Cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,997,240 | August 1, 2023 | July 31, 2030 | THOMPSON, CRAIG B | reporter.nih.gov |
| Role of Microglia Somatic Variants in Neurodegenerative Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,988,237 | September 15, 2019 | May 31, 2025 | GEISSMANN, FREDERIC | reporter.nih.gov |
| Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma | NIH | National Cancer Institute | 2022 to 2025 | $2,969,354 | September 1, 2025 | August 31, 2027 | CHEN, YU | reporter.nih.gov |
| Regulation of tumor suppression by alpha-ketoglutarate | NIH | National Cancer Institute | 2021 to 2025 | $2,938,818 | August 6, 2025 | July 31, 2027 | FINLEY, LYDIA | reporter.nih.gov |
| Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity) | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,934,484 | June 11, 2022 | February 28, 2027 | GANY, FRANCESCA M | reporter.nih.gov |
| Molecular Mechanisms of Drug Resistance in Primary Brain Tumors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,926,627 | January 1, 2018 | November 30, 2025 | MELLINGHOFF, INGO K | reporter.nih.gov |
| Selective regulatory and biogenesis mechanisms for microRNAs | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,915,145 | September 21, 2007 | August 31, 2029 | LAI, ERIC C | reporter.nih.gov |
| Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,885,730 | July 1, 2022 | June 30, 2027 | BERGER, MICHAEL F. | reporter.nih.gov |
| Mechanoregulation of cytotoxic lymphocyte function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,881,658 | February 15, 2010 | June 30, 2026 | HUSE, MORGAN A | reporter.nih.gov |
| Metabolic control of normal and malignant hematopoiesis | NIH | National Cancer Institute | 2021 to 2025 | $2,869,404 | September 1, 2020 | May 31, 2027 | INTLEKOFER, ANDREW MICHAEL | reporter.nih.gov |
| The IMproving Access to Genetic INformation for Everyone (IMAGINE) Study: A Prospective Trial of a Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Cancer Patients | NIH | National Cancer Institute | 2021 to 2025 | $2,867,395 | September 16, 2020 | August 31, 2027 | HAMILTON, JADA GABRIELLE | reporter.nih.gov |
| Regulation of genome replication, recombination, and stress response | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,849,906 | September 20, 2022 | August 31, 2027 | ZHAO, XIAOLAN | reporter.nih.gov |
| Regulation of protein multi-functionality by 3 UTRs | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,832,000 | February 14, 2022 | December 31, 2026 | MAYR, CHRISTINE | reporter.nih.gov |
| Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity | NIH | National Cancer Institute | 2022 to 2025 | $2,828,375 | September 1, 2022 | August 31, 2027 | BALACHANDRAN, VINOD P | reporter.nih.gov |
| Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) | NIH | National Cancer Institute | 2021 to 2024 | $2,818,159 | June 1, 2020 | May 31, 2025 | MAO, JUN J | reporter.nih.gov |
| Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,799,371 | June 1, 2022 | May 31, 2027 | MUKHERJEE, SEMANTI | reporter.nih.gov |
| Discovery of diabetes-relevant ò cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,792,424 | September 15, 2020 | June 30, 2025 | HUANGFU, DANWEI | reporter.nih.gov |
| Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases | NIH | National Cancer Institute | 2022 to 2025 | $2,738,894 | April 1, 2022 | July 31, 2027 | COHEN, OURI | reporter.nih.gov |
| Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy | NIH | National Cancer Institute | 2022 to 2025 | $2,733,165 | May 1, 2022 | April 30, 2027 | PILLARSETTY, NAGAVARAKISHORE | reporter.nih.gov |
| Molecular Pathogenesis and Therapy of Systemic Histiocytic Neoplasms | NIH | National Cancer Institute | 2021 to 2025 | $2,728,184 | April 1, 2021 | March 31, 2027 | DIAMOND, ELI LOUS | reporter.nih.gov |
| Development of the resident macrophage lineage in mouse and human | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,710,279 | February 8, 2017 | December 31, 2027 | GEISSMANN, FREDERIC | reporter.nih.gov |
| Development of large-field-of-view hyperpolarized MRI | NIH | National Cancer Institute | 2021 to 2024 | $2,676,537 | December 1, 2019 | November 30, 2024 | KESHARI, KAYVAN R | reporter.nih.gov |
| Autoimmune Stem-like CD8 T cells in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,657,421 | June 8, 2023 | May 31, 2028 | SCHIETINGER, ANDREA | reporter.nih.gov |
| Mycobacterial DNA repair and mutagenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,655,624 | February 1, 2005 | May 31, 2025 | GLICKMAN, MICHAEL S | reporter.nih.gov |
| Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,654,692 | July 1, 2020 | June 30, 2026 | SCHWARTZ, LAWRENCE H | reporter.nih.gov |
| Rethinking the "quiet" nature of apoptotic cell clearance. | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,649,000 | September 23, 2021 | August 31, 2026 | PERRY, JUSTIN S | reporter.nih.gov |
| Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient | NIH | National Cancer Institute | 2021 to 2025 | $2,633,017 | March 1, 2025 | June 30, 2025 | SMITH, JESSE JOSHUA | reporter.nih.gov |
| Visualizing oxidative stress using hyperpolarized magnetic resonance | NIH | National Cancer Institute | 2021 to 2024 | $2,607,387 | June 1, 2020 | May 31, 2026 | KESHARI, KAYVAN R | reporter.nih.gov |
| Investigational Cancer Therapeutics Training Program (ICTTP) | NIH | National Cancer Institute | 2021 to 2025 | $2,602,722 | September 30, 1977 | August 31, 2029 | DRILON, ALEXANDER | reporter.nih.gov |
| Cancer and Aging Reflections for Elders (CARE): A Geriatric-Specific Psychotherapy for Older Adults with Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,601,751 | June 1, 2020 | May 31, 2026 | NELSON, CHRISTIAN J | reporter.nih.gov |
| Impact of the aging niche on cancer phenotypes probed using mouse cancer models produced by somatic engineering. | NIH | National Institute on Aging | 2021 to 2025 | $2,597,894 | September 30, 2021 | August 31, 2026 | LOWE, SCOTT W. | reporter.nih.gov |
| Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene. | NIH | National Cancer Institute | 2021 to 2025 | $2,596,206 | April 1, 2021 | March 31, 2026 | KLEBANOFF, CHRISTOPHER AUSTIN | reporter.nih.gov |
| Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR) | NIH | National Cancer Institute | 2021 to 2024 | $2,581,284 | September 10, 2020 | August 31, 2025 | JARNAGIN, WILLIAM ROBERT | reporter.nih.gov |
| The gut endoderm: origin, formation and fate | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,579,615 | February 1, 2021 | January 31, 2025 | HADJANTONAKIS, ANNA-KATERINA | reporter.nih.gov |
| Interrogating the minor spliceosome to understand and treat leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,577,584 | July 3, 2020 | June 30, 2025 | ABDEL-WAHAB, OMAR | reporter.nih.gov |
| Regulation of y-secretase activity by modulatory proteins | NIH | National Institute on Aging | 2021 to 2023 | $2,563,119 | February 1, 2019 | November 30, 2024 | LI, YUEMING | reporter.nih.gov |
| Redox control of the NLRP1 inflammasome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,561,375 | June 15, 2021 | May 31, 2026 | BACHOVCHIN, DANIEL | reporter.nih.gov |
| A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity | NIH | National Cancer Institute | 2021 to 2024 | $2,539,571 | September 15, 2020 | August 31, 2025 | GREENBAUM, BENJAMIN | reporter.nih.gov |
| Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,521,819 | June 1, 2021 | May 31, 2027 | CHENG, EMILY H | reporter.nih.gov |
| Uncovering the role for MSI2 network in hematopoietic stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,505,616 | September 15, 2014 | June 30, 2025 | KHARAS, MICHAEL | reporter.nih.gov |
| Lipid Metabolism as a Determinant of Ferroptosis Sensitivity in Cancer | NIH | National Cancer Institute | 2025 | $2,489,032 | August 1, 2025 | July 31, 2030 | JIANG, XUEJUN | reporter.nih.gov |
| Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia | NIH | National Cancer Institute | 2022 to 2025 | $2,488,178 | March 1, 2022 | February 28, 2027 | BACHOVCHIN, DANIEL | reporter.nih.gov |
| Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,478,608 | August 10, 2018 | July 31, 2024 | TAN, DEREK S | reporter.nih.gov |
| Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,469,382 | February 23, 2018 | May 31, 2028 | BACHOVCHIN, DANIEL | reporter.nih.gov |
| Self-Peptides Bound to MHC Class II in T Cell Selection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,462,920 | September 1, 1992 | October 31, 2029 | RUDENSKY, ALEXANDER Y | reporter.nih.gov |
| Ferroptosis, Cellular Metabolism, and Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,451,692 | February 1, 2017 | August 31, 2027 | JIANG, XUEJUN | reporter.nih.gov |
| Small-Molecule Penetration and Efflux in Gram-Negative Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,444,282 | March 1, 2024 | January 31, 2029 | TAN, DEREK S | reporter.nih.gov |
| Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $2,442,853 | April 8, 2021 | March 31, 2026 | HAKIMI, ABRAHAM ARI | reporter.nih.gov |
| Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,438,515 | January 5, 2021 | December 31, 2025 | HSU, KATHARINE C | reporter.nih.gov |
| Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease | NIH | National Institute on Aging | 2023 to 2025 | $2,435,193 | December 1, 2022 | November 30, 2027 | LI, YUEMING | reporter.nih.gov |
| Targeting stem-like cells and their niche in pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,423,178 | January 1, 2025 | December 31, 2026 | TAMMELA, TUOMAS | reporter.nih.gov |
| Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,414,163 | February 1, 2019 | January 31, 2024 | XAVIER, JOAO | reporter.nih.gov |
| Tumor-Selective Delivery Approaches for Medulloblastoma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,405,248 | March 15, 2020 | December 31, 2024 | HELLER, DANIEL ALAN | reporter.nih.gov |
| The natural killer cell response against mouse cytomegalovirus infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,404,919 | January 13, 2023 | December 31, 2027 | SUN, JOSEPH CHAI-YUEN | reporter.nih.gov |
| ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIA | NIH | National Cancer Institute | 2021 to 2025 | $2,398,924 | August 22, 2016 | July 31, 2027 | KENTSIS, ALEX | reporter.nih.gov |
| A Randomized Controlled Trial of Emotion Regulation Therapy for Cancer Caregivers: A Mechanism-Targeted Approach to Addressing Caregiver Distress | NIH | National Cancer Institute | 2021 to 2024 | $2,393,625 | September 1, 2020 | May 31, 2025 | NELSON, CHRISTIAN J | reporter.nih.gov |
| Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,375,342 | July 1, 2009 | January 31, 2026 | CHAUDHURI, JAYANTA | reporter.nih.gov |
| Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers | NIH | National Cancer Institute | 2021 to 2024 | $2,338,594 | September 22, 2020 | June 30, 2025 | OTAZO, RICARDO | reporter.nih.gov |
| Interrogation of the oxidative-stress-induced leukemia program in vivo using metabolic imaging | NIH | National Cancer Institute | 2023 to 2025 | $2,335,453 | July 1, 2023 | June 30, 2028 | KESHARI, KAYVAN R | reporter.nih.gov |
| Essential roles for RNAi/hpRNAs to resolve intragenomic conflicts in the male germline | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,333,198 | May 3, 2022 | April 30, 2027 | LAI, ERIC C | reporter.nih.gov |
| Mechanism and regulation of meiotic recombination | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,317,985 | May 1, 2016 | April 30, 2026 | KEENEY, SCOTT | reporter.nih.gov |
| Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence | NIH | National Cancer Institute | 2021 to 2025 | $2,315,488 | April 1, 2015 | August 31, 2025 | SAWYERS, CHARLES L. | reporter.nih.gov |
| Genetic susceptibility to Barrett's esophagus: From GWAS to biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,315,127 | December 21, 2021 | November 30, 2026 | BUAS, MATTHEW FRANK | reporter.nih.gov |
| Improving efficacy of radioiodine treatment of thyroid cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,314,655 | April 1, 2021 | March 31, 2026 | FAGIN, JAMES A | reporter.nih.gov |
| T cell invasion of the stem cell compartment during immune-mediated GI damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,299,846 | January 1, 2021 | December 31, 2025 | HANASH, ALAN M | reporter.nih.gov |
| HER2-mediated delivery of cytotoxic agents in solid tumors | NIH | National Cancer Institute | 2021 to 2024 | $2,298,246 | April 1, 2021 | March 31, 2025 | CHANDARLAPATY, SARAT | reporter.nih.gov |
| The Breast Cancer and the Workforce Communication App: A randomized controlled trial of an English/Spanish intervention to promote long-term job retention | NIH | National Cancer Institute | 2021 to 2024 | $2,287,303 | February 1, 2023 | January 31, 2026 | BLINDER, VICTORIA S | reporter.nih.gov |
| Development and Validation of Prognostic Radiomic Markers of Response and Recurrence for Patients with Colorectal Liver Metastases | NIH | National Cancer Institute | 2021 to 2023 | $2,284,583 | March 1, 2019 | August 31, 2025 | DO, RICHARD KINH GIAN | reporter.nih.gov |
| Structural studies of RNA processing and ubiquitin-like protein modification | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,278,875 | June 10, 2016 | March 31, 2026 | LIMA, CHRISTOPHER D. | reporter.nih.gov |
| Sizing and Scaling in Functional Muscle Cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,212,596 | June 1, 2021 | May 31, 2027 | BAYLIES, MARY K | reporter.nih.gov |
| Regulation of Proinflammatory Cytokine Responses by a Caspase-8-N4BP1 Axis | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $2,212,500 | September 13, 2022 | August 31, 2027 | GITLIN, ALEXANDER | reporter.nih.gov |
| Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis | NIH | National Cancer Institute | 2021 to 2024 | $2,193,363 | March 1, 2020 | February 28, 2025 | CRAGO, AIMEE MARIE | reporter.nih.gov |
| Obesity, chemotherapy dosing, and breast cancer outcomes | NIH | National Cancer Institute | 2021 to 2024 | $2,193,060 | January 1, 2018 | December 31, 2024 | KANTOR, ELIZABETH DAVID | reporter.nih.gov |
| Mechanisms of Dynamic Transcriptional Reprogramming in Metastasis Stem Cells | NIH | National Cancer Institute | 2022 to 2025 | $2,177,395 | March 1, 2022 | January 31, 2027 | GANESH, KARUNA | reporter.nih.gov |
| Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,173,391 | June 1, 2020 | May 31, 2025 | ABDEL-WAHAB, OMAR | reporter.nih.gov |
| Mechanisms of racial disparity in breast cancer-related lymphedema | NIH | National Cancer Institute | 2023 to 2025 | $2,166,923 | January 1, 2023 | December 31, 2027 | MEHRARA, BABAK J | reporter.nih.gov |
| Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,166,917 | June 6, 2023 | May 31, 2028 | SHAH, SOHRAB P | reporter.nih.gov |
| Targeting immune suppressive microenvironment in ATC | NIH | National Cancer Institute | 2021 to 2025 | $2,163,922 | February 1, 2021 | January 31, 2026 | FAGIN, JAMES A | reporter.nih.gov |
| Template-based replication of the centriole organelle | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,163,020 | August 1, 2009 | December 31, 2027 | TSOU, MENG-FU BRYAN | reporter.nih.gov |
| Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,161,697 | March 22, 2023 | February 29, 2028 | CHI, PING | reporter.nih.gov |
| Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis | NIH | National Cancer Institute | 2023 to 2025 | $2,159,255 | July 3, 2023 | June 30, 2028 | LOWE, SCOTT W. | reporter.nih.gov |
| Cognitive aging in long-term breast cancer survivors | NIH | National Cancer Institute | 2023 to 2025 | $2,158,187 | September 1, 2023 | August 31, 2028 | ROOT, JAMES C | reporter.nih.gov |
| Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture | NIH | National Cancer Institute | 2021 to 2024 | $2,149,252 | July 7, 2021 | January 1, 2025 | KREBS, SIMONE | reporter.nih.gov |
| Discriminating EGFR function in T cells and epithelium during immune-mediated tissue damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,147,877 | August 25, 2018 | June 30, 2028 | HANASH, ALAN M | reporter.nih.gov |
| Decoding cell states and tissue morphogenesis in the early mammalian embryo | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,145,842 | June 21, 2024 | July 31, 2029 | HADJANTONAKIS, ANNA-KATERINA | reporter.nih.gov |
| Studies on oncoprotein-induced feedback: Basic and therapeutic implications | NIH | National Cancer Institute | 2021 to 2022 | $2,133,648 | September 1, 2016 | August 31, 2023 | ROSEN, NEAL | reporter.nih.gov |
| Toward development of senolytic CAR T cells | NIH | National Institute on Aging | 2021 to 2024 | $2,133,137 | May 15, 2020 | February 28, 2025 | LOWE, SCOTT W. | reporter.nih.gov |
| Dissecting KRAS oncoprotein signaling with small molecule inhibitors | NIH | National Cancer Institute | 2021 to 2025 | $2,127,045 | September 1, 2018 | August 31, 2028 | LITO, PIRO | reporter.nih.gov |
| Acceptance of non-self: Decoding intestinal immune tolerance during early life | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,124,000 | August 5, 2022 | July 31, 2027 | BROWN, CHRYSOTHEMIS | reporter.nih.gov |
| RNA-directed targeting of AID in immunity and cancer | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,124,000 | February 1, 2016 | June 30, 2027 | CHAUDHURI, JAYANTA | reporter.nih.gov |
| A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma | NIH | National Cancer Institute | 2021 to 2024 | $2,116,571 | June 1, 2019 | May 31, 2025 | ADUSUMILLI, PRASAD S. | reporter.nih.gov |
| (PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing | NIH | National Cancer Institute | 2021 to 2023 | $2,107,536 | April 1, 2019 | March 31, 2024 | BERGER, MICHAEL F. | reporter.nih.gov |
| Exercise as Interception Therapy in Primary High Risk Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,107,239 | September 3, 2020 | June 30, 2026 | JONES, LEE W | reporter.nih.gov |
| Confocal video-mosaicking microscopy to guide surgery of superficially spreading skin cancers | NIH | National Cancer Institute | 2021 to 2023 | $2,089,031 | July 1, 2019 | June 30, 2025 | RAJADHYAKSHA, MILIND | reporter.nih.gov |
| The MSK Genomic Data Analysis Center for Tumor Evolution | NIH | National Cancer Institute | 2021 to 2025 | $2,085,768 | September 1, 2021 | August 31, 2026 | SCHULTZ, NIKOLAUS | reporter.nih.gov |
| The Human DNA virome: from petabase scale to single-cell resolution | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $2,085,665 | September 20, 2024 | August 31, 2029 | LAREAU, CALEB ANDREW | reporter.nih.gov |
| Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma | NIH | National Cancer Institute | 2023 to 2025 | $2,068,451 | March 13, 2023 | February 29, 2028 | KHARAS, MICHAEL | reporter.nih.gov |
| Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer: | NIH | National Cancer Institute | 2022 to 2024 | $2,054,025 | September 15, 2022 | July 31, 2027 | JONES, LEE W | reporter.nih.gov |
| Defining functional circuits between CN molecular subpopulations and the cerebral cortex | NIH | National Institute of Mental Health | 2021 to 2023 | $2,053,680 | January 21, 2019 | November 30, 2024 | JOYNER, ALEXANDRA L. | reporter.nih.gov |
| Reflectance confocal microscopy-optical coherence tomography (RCM-OCT) imaging of oral lesions: Toward an affordable device and approach for developing countries | NIH | National Cancer Institute | 2023 to 2025 | $2,046,259 | August 15, 2023 | July 31, 2028 | RAJADHYAKSHA, MILIND | reporter.nih.gov |
| Orchestrating intestinal immunity through microbiota-CX3CR1+ cell interactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,035,500 | March 2, 2017 | July 31, 2027 | DIEHL, GRETCHEN E | reporter.nih.gov |
| Investigating microRNA Function in Homeostasis, Regeneration and Cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,031,505 | September 1, 2020 | May 31, 2025 | VENTURA, ANDREA | reporter.nih.gov |
| Characterizing the MSI2 network in leukemia | NIH | National Cancer Institute | 2021 to 2025 | $2,029,035 | April 1, 2015 | November 30, 2025 | KHARAS, MICHAEL | reporter.nih.gov |
| Surgical Oncology Research Training Grant | NIH | National Cancer Institute | 2021 to 2025 | $2,020,610 | September 1, 1984 | July 31, 2030 | MEHRARA, BABAK J | reporter.nih.gov |
| Structural Mechanisms of DNA Damage Sensing and Activation of the ATR, Fanconi Anemia, and ATM Checkpoints | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,017,785 | August 1, 2023 | April 30, 2027 | PAVLETICH, NIKOLA P | reporter.nih.gov |
| Signaling Pathways that Regulate Scaling and Regeneration of the Cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,010,981 | February 1, 2015 | January 31, 2026 | JOYNER, ALEXANDRA L. | reporter.nih.gov |
| Probabilistic Multiscale Modeling of the Tumor Microenvironment | NIH | National Cancer Institute | 2023 to 2025 | $2,001,618 | January 1, 2023 | December 31, 2027 | TANSEY, WESLEY | reporter.nih.gov |
| Deciphering the Acidic Tumor Environment: A Phase I/IIa Study of Pre-Operative Multiparametric MRI and pHLIP® ICG Intra-Operative Fluorescence Imaging of Primary Breast Cancer | NIH | National Cancer Institute | 2023 to 2025 | $2,000,741 | March 1, 2023 | February 28, 2027 | MORROW, MONICA | reporter.nih.gov |
| Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells | NIH | National Cancer Institute | 2021 to 2024 | $1,998,178 | September 1, 2020 | May 31, 2025 | LI, MING | reporter.nih.gov |
| Phase 1a/1b Trial of Exercise Treatment in Hormone Receptor-Positive Metastatic Breast Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,990,761 | April 3, 2019 | March 31, 2024 | IYENGAR, NEIL MUKUND | reporter.nih.gov |
| Ceramide-Rich Platforms Functionalize Gemcitabine Uptake | NIH | National Cancer Institute | 2021 to 2025 | $1,988,000 | January 1, 2021 | December 31, 2025 | KOLESNICK, RICHARD N | reporter.nih.gov |
| Predicting sensitivity and resistance in RET-driven cancers | NIH | National Cancer Institute | 2021 to 2025 | $1,988,000 | April 1, 2021 | March 31, 2027 | DRILON, ALEXANDER | reporter.nih.gov |
| Drivers of histologic transformation in EGFR-mutant lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,988,000 | September 21, 2021 | August 31, 2027 | YU, HELENA | reporter.nih.gov |
| Nanosensor Array Platform to Capture Whole Disease Fingerprints | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $1,980,516 | June 15, 2023 | April 30, 2027 | HELLER, DANIEL ALAN | reporter.nih.gov |
| Post-transcriptional Regulatory Networks | NIH | National Human Genome Research Institute | 2023 to 2025 | $1,977,541 | August 4, 2023 | May 31, 2027 | MORRIS, QUAID | reporter.nih.gov |
| Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT)Trial | NIH | National Cancer Institute | 2021 to 2023 | $1,973,105 | December 1, 2020 | November 30, 2023 | BAO, TING | reporter.nih.gov |
| Human Dopamine Grafts in Alpha-Synuclein Models of Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,967,447 | July 1, 2023 | June 30, 2028 | TABAR, VIVIANE | reporter.nih.gov |
| Multicolor PET to interrogate cancer biology | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $1,960,875 | May 1, 2023 | March 31, 2027 | GRIMM, JAN | reporter.nih.gov |
| Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,959,147 | January 22, 2019 | December 31, 2024 | HOHL, TOBIAS M | reporter.nih.gov |
| Structural and functional principles underlying germline genome transmission | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,950,967 | August 3, 2022 | April 30, 2027 | KEENEY, SCOTT | reporter.nih.gov |
| Cell Intrinsic and Extrinsic Factors Driving Maturation in Human PSC-derived Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,946,321 | August 1, 2023 | July 31, 2028 | STUDER, LORENZ P. | reporter.nih.gov |
| Mechanisms of enhancer-promoter communication, genome organization and transcription control | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,937,160 | August 1, 2022 | April 30, 2026 | PERTSINIDIS, ALEXANDROS | reporter.nih.gov |
| Safer lung cancer radiotherapy delivery using novel artificial intelligence methods | NIH | National Cancer Institute | 2022 to 2025 | $1,925,783 | June 15, 2022 | May 31, 2027 | VEERARAGHAVAN, HARINI | reporter.nih.gov |
| Molecular Imaging in Cancer Biology Training Program | NIH | National Cancer Institute | 2021 to 2025 | $1,919,365 | August 19, 2021 | July 31, 2027 | LEWIS, JASON S. | reporter.nih.gov |
| Immune control and genomic instability at micronuclei | NIH | National Cancer Institute | 2022 to 2025 | $1,916,125 | January 1, 2022 | December 31, 2026 | MACIEJOWSKI, JOHN | reporter.nih.gov |
| FOOD (Food to Overcome Outcomes Disparities) | NIH | National Cancer Institute | 2021 to 2023 | $1,915,218 | June 1, 2018 | May 31, 2025 | GANY, FRANCESCA M | reporter.nih.gov |
| Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies | NIH | National Cancer Institute | 2021 to 2024 | $1,908,434 | January 1, 2020 | December 31, 2024 | LOWE, SCOTT W. | reporter.nih.gov |
| Defining the function of Complex I truncating mutations in cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,896,011 | January 1, 2023 | December 31, 2027 | REZNIK, EDUARD | reporter.nih.gov |
| Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial | NIH | National Cancer Institute | 2021 to 2023 | $1,873,647 | April 1, 2021 | September 30, 2023 | BAO, TING | reporter.nih.gov |
| Body composition and the obesity paradox in clear cell renal cell carcinoma | NIH | National Cancer Institute | 2021 to 2023 | $1,873,079 | August 1, 2019 | July 31, 2025 | FURBERG-BARNES, ANNA HELENA | reporter.nih.gov |
| MIRDCalc – A Community Tool for Deriving and Reporting Patient Organ Doses in Nuclear Medicine, Computed Tomography, and Hybrid Imaging | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,854,415 | September 13, 2019 | May 31, 2025 | KESNER, ADAM LEON | reporter.nih.gov |
| Molecular origins and impact of APOBEC3 mutagenesis in cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,850,023 | September 1, 2022 | August 31, 2027 | MACIEJOWSKI, JOHN | reporter.nih.gov |
| Modeling BRAF-fusion driven pediatric brain tumors in the mouse | NIH | National Cancer Institute | 2021 to 2023 | $1,848,656 | June 1, 2019 | May 31, 2024 | VENTURA, ANDREA | reporter.nih.gov |
| The role of bile acid metabolomics in graft-versus-host disease | NIH | National Cancer Institute | 2021 to 2023 | $1,838,884 | April 1, 2018 | October 16, 2023 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| Replication Of Chromosomes In Budding Yeast | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,822,010 | September 17, 2019 | December 31, 2027 | WHITEHOUSE, IESTYN | reporter.nih.gov |
| T32 Urologic Oncology Research Training Grant | NIH | National Cancer Institute | 2021 to 2025 | $1,820,315 | September 1, 1999 | July 31, 2030 | CARVER, BRETT STEWART | reporter.nih.gov |
| A Phase 1 Trial of MLN0128 (sapanisertib) and CB-839 HCl (telaglenastat) in Advanced NSCLC Patients | NIH | National Cancer Institute | 2021 to 2023 | $1,801,566 | August 31, 2021 | July 31, 2027 | PAIK, PAUL K | reporter.nih.gov |
| TOX-driven CD8 T cell differentiation and dysfunction in tumors | NIH | National Cancer Institute | 2023 to 2025 | $1,797,402 | January 1, 2023 | December 31, 2027 | SCHIETINGER, ANDREA | reporter.nih.gov |
| Ferroptosis and Cancer Cell Signaling | NIH | National Cancer Institute | 2022 to 2025 | $1,791,770 | February 1, 2022 | January 31, 2027 | JIANG, XUEJUN | reporter.nih.gov |
| A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,782,261 | June 1, 2023 | February 28, 2026 | DAR, ARVIN | reporter.nih.gov |
| Targeting plasticity in lung cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,777,231 | January 1, 2023 | December 31, 2027 | TAMMELA, TUOMAS | reporter.nih.gov |
| Mechanism and regulation of Hu family RNA binding proteins during neural alternative polyadenylation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,774,737 | January 15, 2014 | December 31, 2024 | LAI, ERIC C | reporter.nih.gov |
| Mechanisms of lysosomal ion transport proteins involved in pH homeostasis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,770,000 | December 1, 2021 | November 30, 2025 | HITE, RICHARD KEVIN | reporter.nih.gov |
| Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial | NIH | National Cancer Institute | 2023 to 2025 | $1,767,760 | June 1, 2023 | May 31, 2028 | YU, ANTHONY FRANCIS | reporter.nih.gov |
| Investigating histone glycation as a new dynamic epigenetic mark | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,756,804 | July 10, 2020 | April 30, 2025 | DAVID-SHTERNBERG, YAEL E | reporter.nih.gov |
| Genomic biomarkers of splenic lymphoma | NIH | National Cancer Institute | 2022 to 2025 | $1,743,045 | October 1, 2022 | November 30, 2026 | ELENITOBA-JOHNSON, KOJO S. J. | reporter.nih.gov |
| SANOS (SAlud y Nutricion para todOS) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $1,716,699 | September 1, 2018 | March 31, 2025 | LENG, JENNIFER CF | reporter.nih.gov |
| Development and validation of an intraoperative imaging agent for the peripheral nervous system | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,698,454 | June 15, 2020 | February 28, 2024 | PILLARSETTY, NAGAVARAKISHORE | reporter.nih.gov |
| Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropism | NIH | National Cancer Institute | 2023 to 2025 | $1,698,254 | January 1, 2023 | December 31, 2027 | XAVIER, JOAO | reporter.nih.gov |
| Investigating the roles of oncogenic extrachromosomal circular DNAs in cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,671,715 | August 1, 2023 | July 31, 2028 | VENTURA, ANDREA | reporter.nih.gov |
| Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy | NIH | National Cancer Institute | 2023 to 2025 | $1,648,127 | September 13, 2023 | August 31, 2028 | OFFODILE, ANAEZE C | reporter.nih.gov |
| Trial of Meaning Centered Psychotherapy for Mexican Patients with Advanced Cancer | NIH | National Institute of Mental Health | 2024 to 2025 | $1,623,704 | August 1, 2024 | May 31, 2029 | COSTAS-MUNIZ, ROSARIO | reporter.nih.gov |
| Investigating the impact and dynamic of mitochondrial common deletion in somatic cells | NIH | National Institute on Aging | 2023 to 2025 | $1,617,915 | September 30, 2023 | May 31, 2028 | SFEIR, AGNEL | reporter.nih.gov |
| Investigating Microenvironmental Interactions in Leptomeningeal Metastasis | NIH | National Cancer Institute | 2021 to 2024 | $1,614,582 | September 1, 2020 | May 31, 2025 | BOIRE, ADRIENNE A. | reporter.nih.gov |
| Fatty acid signaling in the pancreatic tumor microenvironment | NIH | National Cancer Institute | 2022 to 2025 | $1,614,268 | July 12, 2018 | June 30, 2028 | SHERMAN, MARA H. | reporter.nih.gov |
| Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers | NIH | National Cancer Institute | 2022 to 2025 | $1,612,380 | September 22, 2022 | August 31, 2027 | EASTHAM, JAMES A | reporter.nih.gov |
| Lipid programs in melanocyte transformation | NIH | National Cancer Institute | 2021 to 2025 | $1,606,364 | March 1, 2020 | February 28, 2026 | OVERHOLTZER, MICHAEL H. | reporter.nih.gov |
| Psychosocial Palliative and Community Research in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $1,605,823 | May 1, 1984 | August 31, 2029 | HAY, JENNIFER L | reporter.nih.gov |
| Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,599,645 | May 1, 2023 | April 30, 2028 | LI, MING | reporter.nih.gov |
| Defining the impact of mutant oncogene zygosity | NIH | National Cancer Institute | 2021 to 2024 | $1,583,112 | March 1, 2020 | February 28, 2025 | CHANDARLAPATY, SARAT | reporter.nih.gov |
| Understanding the Importance of Industry Relationships for Cancer Care Quality, Outcomes, and Costs | NIH | National Cancer Institute | 2022 to 2025 | $1,578,009 | August 1, 2022 | July 31, 2027 | MITCHELL, AARON P | reporter.nih.gov |
| Chemical Genetic Dissection of SWI/SNF Chromatin Remodeling Complex Functions in Cerebral Cortex Development | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,577,226 | April 1, 2023 | March 31, 2028 | VIERBUCHEN, THOMAS S | reporter.nih.gov |
| Meaning-Centered Grief Therapy for Parents Bereaved by Cancer: A Multisite Randomized Controlled Trial | NIH | National Institute of Nursing Research | 2021 to 2022 | $1,567,994 | August 26, 2021 | May 25, 2023 | LICHTENTHAL, WENDY G. | reporter.nih.gov |
| Epiproteomics of Sezary Syndrome | NIH | National Cancer Institute | 2022 to 2024 | $1,560,839 | June 1, 2020 | May 31, 2026 | ELENITOBA-JOHNSON, KOJO S. J. | reporter.nih.gov |
| Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH) | NIH | National Cancer Institute | 2024 to 2025 | $1,538,728 | September 1, 2024 | August 31, 2029 | FRIEDMAN, DANIELLE | reporter.nih.gov |
| Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,516,847 | December 1, 2022 | November 30, 2027 | PIETZAK, EUGENE | reporter.nih.gov |
| Mechanisms of adaptation and resistance to emerging therapies for lung cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,516,847 | May 1, 2023 | April 30, 2028 | LITO, PIRO | reporter.nih.gov |
| RSMI HEALS | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,503,249 | August 8, 2024 | February 28, 2029 | GANY, FRANCESCA M | reporter.nih.gov |
| Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK | NIH | National Cancer Institute | 2021 to 2024 | $1,502,540 | December 10, 2018 | November 30, 2024 | YAEGER, RONA | reporter.nih.gov |
| Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries | NIH | National Cancer Institute | 2021 to 2022 | $1,491,465 | April 15, 2017 | April 30, 2024 | KINGHAM, T PETER | reporter.nih.gov |
| Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation | NIH | National Cancer Institute | 2024 to 2025 | $1,477,476 | September 18, 2024 | August 31, 2029 | SHU, XIANG | reporter.nih.gov |
| Understanding lung cancer genomics in patients of African ancestry | NIH | National Cancer Institute | 2024 to 2025 | $1,460,798 | July 1, 2024 | June 30, 2026 | CARROT-ZHANG, JIAN | reporter.nih.gov |
| Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma | NIH | National Cancer Institute | 2021 to 2023 | $1,434,476 | August 1, 2019 | July 31, 2025 | JONES, DAVID R | reporter.nih.gov |
| Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals | NIH | National Institute of Mental Health | 2024 to 2025 | $1,430,567 | November 8, 2023 | October 31, 2028 | STUDER, LORENZ P. | reporter.nih.gov |
| Enhanced Pain Coping in Cancer (EPIC) | NIH | National Cancer Institute | 2024 to 2025 | $1,428,017 | July 1, 2024 | June 30, 2029 | MAO, JUN J | reporter.nih.gov |
| Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapy | NIH | National Cancer Institute | 2024 to 2025 | $1,419,727 | September 4, 2024 | August 31, 2029 | PONOMAREV, VLADIMIR | reporter.nih.gov |
| Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate | NIH | National Cancer Institute | 2024 to 2025 | $1,419,480 | July 2, 2024 | June 30, 2028 | BODEI, LISA | reporter.nih.gov |
| Optimizing Tobacco Treatment for Smokers Seeking Lung Cancer Screening | NIH | National Cancer Institute | 2021 to 2022 | $1,416,144 | August 9, 2016 | November 30, 2023 | OSTROFF, JAMIE S. | reporter.nih.gov |
| Origins and functions of pancreatic cancer-associated fibroblasts | NIH | National Cancer Institute | 2022 to 2025 | $1,411,900 | January 1, 2023 | April 30, 2026 | SHERMAN, MARA H. | reporter.nih.gov |
| ISIC-REPO; ISIC Skin Imaging Repository Enhancements for Promoting Interoperability and Utilization | NIH | National Cancer Institute | 2024 to 2025 | $1,411,293 | April 1, 2024 | March 31, 2029 | HALPERN, ALLAN C | reporter.nih.gov |
| Investigating hypoxia as a determinant of malignant fates in pancreas cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,409,244 | April 1, 2024 | March 31, 2029 | TAMMELA, TUOMAS | reporter.nih.gov |
| Artificial Intelligence powered virtual digital twins to construct and validate AI automated tools for safer MR-guided adaptive RT of abdominal cancers | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $1,408,790 | September 1, 2023 | August 31, 2027 | TYAGI, NEELAM | reporter.nih.gov |
| The Super Argus PET/CT 6R for Pre-clinical Oncology Research | NIH | Office of the Director, National Institutes of Health | 2024 | $1,391,522 | September 1, 2024 | August 14, 2025 | ZANZONICO, PAT B | reporter.nih.gov |
| Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,389,906 | February 7, 2019 | January 31, 2024 | GLICKMAN, MICHAEL S | reporter.nih.gov |
| Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa | NIH | National Cancer Institute | 2021 to 2024 | $1,387,631 | September 8, 2020 | August 31, 2025 | ARCILA, MARIA E | reporter.nih.gov |
| Determining the risk factor profile and biology of colorectal cancer in Nigeria | NIH | National Cancer Institute | 2021 to 2023 | $1,386,615 | August 1, 2020 | April 30, 2025 | KINGHAM, T PETER | reporter.nih.gov |
| Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,377,564 | July 10, 2018 | June 30, 2024 | LEWIS, JASON S. | reporter.nih.gov |
| Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma | NIH | National Cancer Institute | 2023 to 2025 | $1,375,717 | September 21, 2023 | August 31, 2028 | KLEBANOFF, CHRISTOPHER AUSTIN | reporter.nih.gov |
| Assessment of sensory gating, attention, and executive control in breast cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,373,078 | January 1, 2018 | December 31, 2023 | AHLES, TIM ALAN | reporter.nih.gov |
| Novel strategies for induction of aging in human PSC-derived lineages for modeling Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $1,364,918 | September 15, 2017 | March 31, 2030 | STUDER, LORENZ P. | reporter.nih.gov |
| Molecular mechanism of eukaryotic chromosome replication | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,350,554 | August 10, 2024 | July 31, 2029 | REMUS, DIRK | reporter.nih.gov |
| Geriatric Oncology: Cognition and Communication | NIH | National Cancer Institute | 2021 to 2025 | $1,346,905 | September 19, 2019 | November 30, 2029 | PARKER, PATRICIA A | reporter.nih.gov |
| Structure-Activity Based Mechanistic Insights into Cleavage Chemistry by Self-Cleaving Nucleolytic Ribozymes | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,345,200 | September 1, 2022 | June 30, 2026 | PATEL, DINSHAW J | reporter.nih.gov |
| Germline mutagenesis at meiotic double-strand breaks | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,343,042 | August 8, 2023 | April 30, 2028 | JASIN, MARIA | reporter.nih.gov |
| Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,337,158 | June 1, 2020 | June 16, 2023 | BRADBURY, MICHELLE S | reporter.nih.gov |
| Maternal B cells in health and disease. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,336,490 | August 6, 2024 | June 30, 2029 | RIZZUTO, GABRIELLE A | reporter.nih.gov |
| Mechanism of DNA replication initiation in Saccharomyces cerevisiae | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,331,919 | September 5, 2014 | November 30, 2023 | REMUS, DIRK | reporter.nih.gov |
| Intestinal microbiome restoration in allogeneic stem cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,327,500 | May 1, 2023 | April 30, 2028 | PONCE, DORIS | reporter.nih.gov |
| Third-party “off the shelf” mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,326,660 | August 1, 2019 | June 30, 2023 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center | NIH | National Cancer Institute | 2021 | $1,323,213 | September 30, 2017 | August 31, 2023 | SAWYERS, CHARLES L. | reporter.nih.gov |
| Tuning KITv CAR T cells for the solid tumor environment | NIH | National Cancer Institute | 2024 to 2025 | $1,310,084 | August 13, 2024 | July 31, 2029 | ADUSUMILLI, PRASAD S. | reporter.nih.gov |
| Structural basis of eukaryotic clamp loading | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,308,792 | March 1, 2024 | December 31, 2028 | REMUS, DIRK | reporter.nih.gov |
| Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS) | NIH | National Cancer Institute | 2023 to 2025 | $1,297,165 | September 15, 2023 | June 30, 2028 | PANAGEAS, KATHERINE S | reporter.nih.gov |
| Systematic characterization of cancer variants using single-cell functional genomics | NIH | National Cancer Institute | 2022 to 2024 | $1,291,335 | April 1, 2022 | March 31, 2026 | NORMAN, THOMAS MAXWELL | reporter.nih.gov |
| Molecular Glues to Target RAS-MAPK Driven Cancers | NIH | National Cancer Institute | 2023 to 2025 | $1,291,324 | July 1, 2023 | February 29, 2028 | DAR, ARVIN | reporter.nih.gov |
| The cBioPortal for Cancer Genomics | NIH | National Cancer Institute | 2021 | $1,281,528 | August 1, 2017 | September 30, 2022 | SCHULTZ, NIKOLAUS | reporter.nih.gov |
| Genetic Analysis of Morphogenesis in the Mouse Embryo | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,271,232 | July 1, 1998 | July 31, 2024 | HADJANTONAKIS, ANNA-KATERINA | reporter.nih.gov |
| Molecular Pathophysiology of Thyroid Cell Growth | NIH | National Cancer Institute | 2021 to 2023 | $1,271,119 | August 1, 1989 | November 30, 2024 | FAGIN, JAMES A | reporter.nih.gov |
| MSK Computational Biology Summer Program | NIH | National Cancer Institute | 2021 to 2025 | $1,268,762 | July 1, 2019 | June 30, 2029 | BERGER, MICHAEL F. | reporter.nih.gov |
| P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment | NIH | National Cancer Institute | 2021 to 2022 | $1,265,754 | December 15, 2017 | November 30, 2024 | HELLER, DANIEL ALAN | reporter.nih.gov |
| Role of TET2 mutations in malignant transformation and acute myeloid leukemia | NIH | National Cancer Institute | 2021 to 2022 | $1,265,588 | February 7, 2013 | May 31, 2025 | LEVINE, ROSS L | reporter.nih.gov |
| Mechanisms and Function of Autophagy in Cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,262,588 | January 1, 2013 | December 31, 2023 | JIANG, XUEJUN | reporter.nih.gov |
| Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy | NIH | National Cancer Institute | 2024 to 2025 | $1,262,391 | September 15, 2024 | August 31, 2029 | SANTOMASSO, BIANCA DENISE | reporter.nih.gov |
| Dissecting the complexity of metastasis with mathematical models and quantitative experiments with in zebrafish | NIH | National Cancer Institute | 2021 to 2022 | $1,250,827 | September 1, 2018 | August 31, 2024 | XAVIER, JOAO | reporter.nih.gov |
| Clinical Scholars Biomedical Research Training Program | NIH | National Cancer Institute | 2021 to 2025 | $1,247,597 | February 1, 1985 | August 31, 2028 | CHI, PING | reporter.nih.gov |
| Investigating the contribution of cellular senescence to the efficacy of radiation therapy. | NIH | National Cancer Institute | 2021 to 2025 | $1,237,994 | September 1, 2021 | August 31, 2026 | ROMESSER, PAUL BERNARD | reporter.nih.gov |
| Investigating telomerase dynamics in live cells at a single-molecule level | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,232,145 | September 1, 2023 | June 30, 2027 | SFEIR, AGNEL | reporter.nih.gov |
| Mechanisms of Lipid Droplet Formation | NIH | National Institute of General Medical Sciences | 2022 to 2024 | $1,232,079 | September 1, 2017 | July 31, 2025 | FARESE, ROBERT V | reporter.nih.gov |
| Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint | NIH | National Cancer Institute | 2021 to 2023 | $1,229,239 | December 2, 2020 | November 30, 2023 | THOMPSON, CRAIG B | reporter.nih.gov |
| Studies on the effects of a novel intermittent therapy on intratumoral clonal architecture and resistance | NIH | National Cancer Institute | 2021 to 2023 | $1,224,288 | February 15, 2019 | January 31, 2025 | LITO, PIRO | reporter.nih.gov |
| Defining mechanisms of resistance to hormonal therapy in breast cancer | NIH | National Cancer Institute | 2021 to 2023 | $1,216,071 | December 5, 2018 | November 30, 2024 | SOLIT, DAVID B. | reporter.nih.gov |
| Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma | NIH | National Cancer Institute | 2021 to 2023 | $1,216,071 | February 1, 2019 | January 31, 2024 | AL-AHMADIE, HIKMAT | reporter.nih.gov |
| Molecular characterization of the multi-modal regulation of inositol 1,4,5-trisphosphate receptors | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,200,069 | April 1, 2019 | January 31, 2024 | HITE, RICHARD KEVIN | reporter.nih.gov |
| Harnessing Rare Variants for Tumor Classification | NIH | National Cancer Institute | 2021 to 2023 | $1,198,468 | April 1, 2021 | March 31, 2025 | SHEN, RONGLAI | reporter.nih.gov |
| Organic Synthesis at the Service of Biology and Medicine | NIH | National Cancer Institute | 2021 to 2025 | $1,193,775 | September 17, 2019 | August 31, 2029 | OUERFELLI, OUATHEK | reporter.nih.gov |
| Selective interactome vulnerability across the Alzheimer’s disease spectrum | NIH | National Institute on Aging | 2021 | $1,162,517 | May 15, 2021 | April 30, 2023 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Expanding cancer research capacity in Nigeria with team science | NIH | National Cancer Institute | 2022 to 2025 | $1,160,841 | March 8, 2022 | February 28, 2027 | KINGHAM, T PETER | reporter.nih.gov |
| Mechanistic basis for endoplasmic reticulum-driven cytoprotection by selective autophagy in neurons | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,160,388 | June 1, 2024 | May 31, 2029 | ORDUREAU, ALBAN | reporter.nih.gov |
| Image-guided TRAIL-enhanced CAR T-cell immunotherapy | NIH | National Cancer Institute | 2021 to 2022 | $1,142,717 | April 1, 2018 | March 31, 2023 | PONOMAREV, VLADIMIR | reporter.nih.gov |
| A Mechanoimmunological Basis for Metastatic Site Preference | NIH | National Cancer Institute | 2024 to 2025 | $1,135,068 | August 1, 2024 | July 31, 2029 | HUSE, MORGAN A | reporter.nih.gov |
| International Study of Subsequent Colorectal Cancer Among Survivors of Childhood, Adolescent, and Young Adult Cancers (I-SCRY) | NIH | National Cancer Institute | 2022 to 2024 | $1,132,151 | February 8, 2022 | January 31, 2026 | MOSKOWITZ, CHAYA | reporter.nih.gov |
| Targeting the ROR2/p-GSK3bS9 pathway to suppress metastasis in SMARCA4-deficient lung adenocarcinoma | NIH | National Cancer Institute | 2024 to 2025 | $1,127,382 | July 2, 2024 | June 30, 2026 | JONES, DAVID R | reporter.nih.gov |
| BMT Core - MSK | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,119,450 | September 30, 2001 | June 30, 2031 | PERALES, MIGUEL-ANGEL | reporter.nih.gov |
| HER2 PET imaging to assess HER2 heterogeneity and predict response to HER2-targeted ADC therapy in urothelial carcinoma | NIH | National Cancer Institute | 2024 to 2025 | $1,113,443 | April 1, 2024 | March 31, 2029 | IYER, GOPA | reporter.nih.gov |
| Nutrient Sensing and mTORC1 Signaling in the Control of Regulatory T Cell Generation and Function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,077,600 | December 3, 2013 | March 31, 2023 | LI, MING | reporter.nih.gov |
| Teaching free energy calculations to learn | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,077,120 | March 1, 2024 | February 28, 2029 | CHODERA, JOHN DAMON | reporter.nih.gov |
| Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis | NIH | National Cancer Institute | 2021 to 2022 | $1,064,193 | May 7, 2018 | April 30, 2024 | CHENG, EMILY H | reporter.nih.gov |
| Identifying and targeting neoantigens in aggressive salivary carcinomas | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $1,063,994 | April 1, 2018 | March 31, 2024 | MORRIS, LUC GORDON TRANG | reporter.nih.gov |
| Social genomic mechanisms linking geographic location to breast cancer survival | NIH | National Cancer Institute | 2024 to 2025 | $1,061,376 | September 1, 2024 | August 31, 2029 | GOEL, NEHA | reporter.nih.gov |
| Meaning-Centered Psychotherapy Training Program for Cancer Care Clinicians | NIH | National Cancer Institute | 2021 to 2024 | $1,059,699 | September 1, 2015 | August 31, 2025 | BREITBART, WILLIAM | reporter.nih.gov |
| Assessing lineage infidelity, oncogenic cooperativity and dependency in RUNX1-mutant acute myeloid leukemia | NIH | National Cancer Institute | 2022 to 2025 | $1,056,740 | July 22, 2022 | June 30, 2026 | XIAO, WENBIN | reporter.nih.gov |
| Proximity Copy Paste: A methodology for single-molecule analysis of chromosome structure | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,056,000 | September 30, 2024 | July 31, 2028 | WHITEHOUSE, IESTYN | reporter.nih.gov |
| Overcoming Resistance to Targeted Therapy in Breast Cancer | NIH | National Cancer Institute | 2025 | $1,056,000 | August 20, 2025 | July 31, 2032 | CHANDARLAPATY, SARAT | reporter.nih.gov |
| Investigating altered T-cell metabolism during chronic antigen encounter | NIH | National Cancer Institute | 2021 to 2024 | $1,052,136 | April 1, 2020 | March 31, 2025 | VARDHANA, SANTOSHA | reporter.nih.gov |
| Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity | NIH | National Cancer Institute | 2021 to 2024 | $1,052,136 | May 1, 2020 | April 30, 2026 | KHALIL, DANNY | reporter.nih.gov |
| Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis | NIH | National Cancer Institute | 2022 to 2023 | $1,041,861 | October 1, 2022 | June 30, 2024 | ELENITOBA-JOHNSON, KOJO S. J. | reporter.nih.gov |
| Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence | NIH | National Cancer Institute | 2021 to 2024 | $1,040,396 | July 1, 2020 | June 30, 2026 | BOTT, MATTHEW J | reporter.nih.gov |
| Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation | NIH | National Cancer Institute | 2021 to 2022 | $1,039,389 | March 1, 2018 | February 28, 2023 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| Desmoplastic small round cell tumor: harnessing new insights and new models | NIH | National Cancer Institute | 2024 to 2025 | $1,036,808 | September 1, 2024 | August 31, 2029 | LADANYI, MARC | reporter.nih.gov |
| Understanding and Targeting Aberrant RNA Splicing in Leukemia | NIH | National Cancer Institute | 2025 | $1,034,176 | August 18, 2025 | July 31, 2032 | ABDEL-WAHAB, OMAR | reporter.nih.gov |
| Uncovering Epigenetic and Transcriptional Drivers of Neuroendocrine Plasticity at Single-Cell Level in Patients with Small Cell Lung Cancer Transformation | NIH | National Cancer Institute | 2022 to 2025 | $1,031,792 | December 15, 2021 | November 30, 2026 | CHAN, JOSEPH MINHOW | reporter.nih.gov |
| Structure and function of genome plasticity in human cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,029,408 | December 13, 2017 | November 30, 2023 | KENTSIS, ALEX | reporter.nih.gov |
| Investigating apoptotic priming as a determinant of sensitivity to leukemia-directed therapies | NIH | National Cancer Institute | 2021 to 2024 | $1,020,180 | July 1, 2021 | June 30, 2025 | CAI, SHENG | reporter.nih.gov |
| Molecular mechanisms of replication-coupled chromatin assembly | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,020,150 | September 1, 2019 | July 31, 2023 | REMUS, DIRK | reporter.nih.gov |
| Lipid Droplets and Transcriptional Regulation of Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,015,465 | April 1, 2020 | February 28, 2026 | WALTHER, TOBIAS C | reporter.nih.gov |
| Mechanisms of COPII-Dependent Quality Control and ER Export | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,013,413 | February 1, 2019 | December 31, 2024 | GOLDBERG, JONATHAN D | reporter.nih.gov |
| A multi-faceted intervention to promote breast cancer hormone receptor testing in Tanzania | NIH | National Cancer Institute | 2021 to 2025 | $1,007,755 | September 13, 2021 | December 31, 2026 | NG, DIANNA L. | reporter.nih.gov |
| Summer research experiences for medical students supervised by faculty mentors | NIH | National Cancer Institute | 2021 to 2025 | $1,000,905 | July 1, 1977 | January 31, 2029 | ARIYAN, CHARLOTTE EIELSON | reporter.nih.gov |
| Determining the role and function of a high plasticity cell state in lung adenocarcinoma | NIH | National Cancer Institute | 2022 to 2025 | $998,104 | August 22, 2022 | July 31, 2027 | CHAN, JASON EARL | reporter.nih.gov |
| Investigating PolQ-mediated alternative NHEJ in breast cancer | NIH | National Cancer Institute | 2021 to 2023 | $997,276 | June 10, 2021 | January 31, 2026 | SFEIR, AGNEL | reporter.nih.gov |
| Acupuncture for Cognitive Health in Older Survivors of Prostate Cancer (ACHIEVE) | NIH | National Cancer Institute | 2022 to 2025 | $990,335 | August 1, 2022 | July 31, 2027 | LIOU, KEVIN T | reporter.nih.gov |
| Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer | NIH | National Cancer Institute | 2021 to 2022 | $987,409 | April 1, 2018 | March 31, 2024 | CHI, PING | reporter.nih.gov |
| The role of B-cells in the anti-tumor immune response in triple negative breast cancer | NIH | National Cancer Institute | 2022 to 2025 | $986,679 | May 9, 2022 | April 30, 2027 | DOWNS-CANNER, STEPHANIE M | reporter.nih.gov |
| Tobacco Treatment Training for Cancer Care Providers | NIH | National Cancer Institute | 2021 to 2025 | $975,031 | August 1, 2017 | June 30, 2028 | OSTROFF, JAMIE S. | reporter.nih.gov |
| Circulating biomarkers of ALK+ anaplastic large cell lymphoma | NIH | National Cancer Institute | 2022 to 2024 | $974,438 | October 1, 2022 | July 31, 2025 | LIM, MEGAN S. | reporter.nih.gov |
| Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles | NIH | National Cancer Institute | 2021 to 2023 | $973,528 | March 1, 2020 | June 29, 2023 | BRADBURY, MICHELLE S | reporter.nih.gov |
| BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma | NIH | National Cancer Institute | 2021 to 2022 | $966,374 | December 1, 2017 | November 30, 2023 | JONES, DAVID R | reporter.nih.gov |
| Targeting isocitrate dehydrogenase mutations by enzyme hyperactivation | NIH | National Cancer Institute | 2024 to 2025 | $949,520 | February 1, 2024 | January 31, 2029 | INTLEKOFER, ANDREW MICHAEL | reporter.nih.gov |
| Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy | NIH | National Cancer Institute | 2021 to 2022 | $930,195 | May 15, 2021 | September 15, 2022 | MERGHOUB, TAHA | reporter.nih.gov |
| Graduate Research Fellowship Program (GRFP) | NSF | Scholarships, Fellowships, and Traineeships Section | 2022 | $921,084 | August 15, 2022 | July 31, 2027 | Michael Overholtzer | nsf.gov |
| DOTA-based pre-targeting of alpha emitters | NIH | National Cancer Institute | 2021 to 2022 | $918,123 | December 10, 2018 | December 31, 2021 | CHEAL, SARAH MARIE | reporter.nih.gov |
| In vivio single-cell analysis of dynamic cell behaviors | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $912,472 | March 1, 2024 | January 31, 2028 | HADJANTONAKIS, ANNA-KATERINA | reporter.nih.gov |
| Behavioral Activation for Depression in Older Adult Cancer Survivors: Pilot Randomized Control Trial and Implementation Outcomes | NIH | National Cancer Institute | 2021 to 2025 | $901,754 | April 1, 2021 | March 31, 2027 | SARACINO, REBECCA | reporter.nih.gov |
| The role of chromosomal instability in tumor evolution | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $898,000 | September 7, 2018 | August 31, 2024 | BAKHOUM, SAMUEL F | reporter.nih.gov |
| Mechanisms of fibrosis in post-surgical lymphedema | NIH | National Heart, Lung, and Blood Institute | 2021 | $897,335 | September 1, 2012 | November 30, 2022 | MEHRARA, BABAK J | reporter.nih.gov |
| Regulation of replication and recombination intermediates | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $894,214 | August 1, 2019 | May 31, 2023 | ZHAO, XIAOLAN | reporter.nih.gov |
| Lipotoxic Protective Response of the Endoplasmic Reticulum | NIH | National Institute of General Medical Sciences | 2022 to 2024 | $891,266 | April 1, 2021 | January 31, 2026 | FARESE, ROBERT V | reporter.nih.gov |
| Advanced machine learning to empower ultra-sensitive liquid biopsy in melanoma and non-small cell lung cancer | NIH | National Cancer Institute | 2023 to 2025 | $877,791 | July 4, 2023 | June 30, 2028 | WIDMAN, ADAM | reporter.nih.gov |
| Mechanisms and therapeutic potential of the autophagy-lysosome pathway in Alzheimer’s disease | NIH | National Institute on Aging | 2025 | $871,093 | January 1, 2025 | December 31, 2029 | LI, YUEMING | reporter.nih.gov |
| Genomic biomarkers for cutaneous T-cell Lymphoma | NIH | National Cancer Institute | 2022 to 2024 | $861,358 | October 1, 2022 | January 31, 2026 | LIM, MEGAN S. | reporter.nih.gov |
| Define the Role of POT1 Mutation in Genome Instability and Cancer | NIH | National Cancer Institute | 2021 to 2022 | $842,937 | April 1, 2021 | August 31, 2024 | SFEIR, AGNEL | reporter.nih.gov |
| A Targeted Approach to the Surveillance of Precursor Lesions for Gastric Cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $838,080 | May 1, 2021 | March 31, 2026 | LASZKOWSKA, MONIKA | reporter.nih.gov |
| A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells | NIH | National Cancer Institute | 2023 to 2025 | $833,055 | August 7, 2023 | July 31, 2028 | SHOUVAL, RONI | reporter.nih.gov |
| Lineage identification and targeted therapeutics in acute leukemia | NIH | National Cancer Institute | 2021 to 2023 | $820,041 | May 1, 2019 | August 25, 2024 | GLASS, JACOB LOWELL | reporter.nih.gov |
| Regulation of the intestinal stem cell compartment after hematopoietic transplantation | NIH | National Heart, Lung, and Blood Institute | 2025 | $819,236 | September 15, 2015 | May 31, 2029 | HANASH, ALAN M | reporter.nih.gov |
| Development of optimal strategies to inhibit ERK signaling in tumors with RAF and MEK mutations | NIH | National Cancer Institute | 2021 to 2022 | $813,453 | June 14, 2018 | May 31, 2024 | SOLIT, DAVID B. | reporter.nih.gov |
| Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors | NIH | National Cancer Institute | 2021 to 2022 | $813,453 | August 15, 2018 | July 31, 2024 | ADUSUMILLI, PRASAD S. | reporter.nih.gov |
| Defining the role of GNAS in gastrointestinal metastasis | NIH | National Cancer Institute | 2023 to 2025 | $806,478 | April 1, 2023 | March 31, 2028 | FOOTE, MICHAEL | reporter.nih.gov |
| Neoadjuvant Tucatinib plus Trastuzumab in HER2-amplified Locally Advanced Rectal Cancer | NIH | National Cancer Institute | 2024 to 2025 | $805,200 | March 1, 2024 | February 28, 2029 | CERCEK, ANDREA | reporter.nih.gov |
| Understanding Resistance to Next Generation Antiandrogens | NIH | National Cancer Institute | 2021 to 2022 | $800,118 | May 1, 2012 | December 31, 2023 | SAWYERS, CHARLES L. | reporter.nih.gov |
| Mechanisms of Lipid Droplet Protein Targeting | NIH | National Institute of General Medical Sciences | 2022 to 2024 | $795,473 | September 30, 2011 | November 30, 2024 | WALTHER, TOBIAS C | reporter.nih.gov |
| Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell Carcinoma | NIH | National Cancer Institute | 2023 to 2025 | $792,330 | July 1, 2023 | June 30, 2028 | CARLO, MARIA | reporter.nih.gov |
| Approaches for engineering transcriptional state of fibroblasts and other differentiated cell types | NIH | National Human Genome Research Institute | 2025 | $789,739 | September 19, 2025 | August 31, 2029 | NORMAN, THOMAS MAXWELL | reporter.nih.gov |
| Multi-antigen-specific CAR T cells to treat acute myeloid leukemia | NIH | National Cancer Institute | 2021 to 2023 | $789,102 | September 1, 2020 | June 30, 2024 | JAMES, SCOTT E | reporter.nih.gov |
| Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer | NIH | National Cancer Institute | 2022 to 2025 | $776,496 | September 1, 2022 | August 31, 2027 | MATULEWICZ, RICHARD STEVEN | reporter.nih.gov |
| Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) | NIH | National Institute on Minority Health and Health Disparities | 2025 | $764,143 | April 29, 2025 | November 30, 2029 | LENG, JENNIFER CF | reporter.nih.gov |
| The Genetic Epidemiology of Radiation-Associated Contralateral Breast Cancer | NIH | National Cancer Institute | 2025 | $752,049 | May 6, 2025 | April 30, 2030 | BERNSTEIN, JONINE L. | reporter.nih.gov |
| New approaches for leveraging single-cell data to identify disease-critical genes and gene sets | NIH | National Human Genome Research Institute | 2023 to 2025 | $747,000 | March 10, 2023 | February 28, 2026 | DEY, KUSHAL KUMAR | reporter.nih.gov |
| Charting somatic evolution via single-cell multiomics | NIH | National Human Genome Research Institute | 2023 to 2025 | $747,000 | September 1, 2023 | August 31, 2026 | LAREAU, CALEB ANDREW | reporter.nih.gov |
| Therapeutic targeting of RTK protein granules in cancer | NIH | National Cancer Institute | 2023 to 2025 | $745,632 | June 1, 2023 | May 31, 2028 | TULPULE, ASMIN | reporter.nih.gov |
| Reducing the chasm in behavioral health care for older adults with cancer: Development of the Center for Implementation Research in Cancer in Later Life (CIRCL) | NIH | National Cancer Institute | 2025 | $743,641 | August 1, 2023 | July 31, 2028 | MCCONNELL, KELLY | reporter.nih.gov |
| Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D | NIH | National Human Genome Research Institute | 2021 | $742,538 | February 1, 2017 | January 31, 2022 | LESLIE, CHRISTINA S | reporter.nih.gov |
| Understanding Ancestral Contribution to Lung Adenocarcinoma | NIH | National Cancer Institute | 2022 to 2024 | $738,480 | August 1, 2022 | July 31, 2025 | ZHANG, JIAN | reporter.nih.gov |
| Mechanistic studies of the menthol receptor TRPM8: a novel target for analgesic drugs | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $738,361 | September 1, 2019 | August 31, 2024 | DIVER, MELINDA | reporter.nih.gov |
| Mechanism and Significance of HMG Co-A Synthase 1 Degradation | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $736,410 | May 7, 2024 | March 31, 2029 | AN, HEESEON | reporter.nih.gov |
| Antigen-specific radiosensitization | NIH | National Cancer Institute | 2025 | $736,168 | August 1, 2025 | July 31, 2030 | HIGGINSON, DANIEL | reporter.nih.gov |
| Exploring PSMA Biology in Tumor neovasculature | NIH | National Cancer Institute | 2021 | $731,830 | June 6, 2017 | May 31, 2022 | GRIMM, JAN | reporter.nih.gov |
| Metabolic control of malignant fates in lung cancer | NIH | National Cancer Institute | 2025 | $730,400 | December 1, 2024 | November 30, 2029 | FINLEY, LYDIA | reporter.nih.gov |
| Inflammatory Signaling in the Leptomeninges | NIH | National Cancer Institute | 2025 | $730,398 | March 11, 2025 | February 28, 2030 | BOIRE, ADRIENNE A. | reporter.nih.gov |
| Leveraging Radiation-Induced Senescence and PTPN2 Inhibition to Enhance Immune-Mediated Tumor Control in Rectal Cancer | NIH | National Cancer Institute | 2025 | $730,398 | September 1, 2025 | August 31, 2030 | ROMESSER, PAUL BERNARD | reporter.nih.gov |
| Improving CDK4/6 inhibition therapy for patients with liposarcoma by understanding resistance | NIH | National Cancer Institute | 2025 | $727,732 | June 3, 2025 | May 31, 2030 | TAP, WILLIAM D. | reporter.nih.gov |
| 'Class I and III Multi-subunit CRISPR-Cas Surveillance Complexes: Recognition, Cleavage, Autoimmunity and Inhibition’ | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $718,400 | April 8, 2019 | March 31, 2024 | PATEL, DINSHAW J | reporter.nih.gov |
| Cerenkov 2.0 – Cerenkov-activated agents for imaging and therapy | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 | $716,758 | September 15, 2022 | September 14, 2024 | GRIMM, JAN | reporter.nih.gov |
| Addressing cancer disparities in Nigeria through Immuno-oncology Research – The NOLA Program | NIH | National Cancer Institute | 2024 to 2025 | $716,532 | September 16, 2024 | August 31, 2026 | KINGHAM, T PETER | reporter.nih.gov |
| DLL3-targeted IL18-secreting CAR T cells in Small Cell Lung Cancer | NIH | National Cancer Institute | 2025 | $716,521 | August 25, 2025 | July 31, 2030 | SCHOENFELD, ADAM J | reporter.nih.gov |
| Development of 3D interferometric super-resolution methods for imaging dynamic, multi-component molecular systems, in single cells and in multi-cellular environments | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $715,584 | September 23, 2019 | May 31, 2025 | PERTSINIDIS, ALEXANDROS | reporter.nih.gov |
| Practical Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL) | NIH | National Cancer Institute | 2025 | $700,611 | March 11, 2025 | February 28, 2030 | ROTEMBERG, VERONICA MIRIAM | reporter.nih.gov |
| Smart and self-reporting clinical nano carriers for drug delivery | NIH | National Cancer Institute | 2021 | $691,044 | March 1, 2017 | February 28, 2022 | GRIMM, JAN | reporter.nih.gov |
| Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining | NIH | National Cancer Institute | 2025 | $683,089 | December 1, 2024 | November 30, 2029 | NADEEM, SAAD | reporter.nih.gov |
| Myeloma Defining Genomic Events to Differentiate Benign and Malignant Myeloma Precursor Conditions | NIH | National Cancer Institute | 2025 | $674,439 | February 3, 2025 | May 31, 2030 | MAURA, FRANCESCO | reporter.nih.gov |
| Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell Lung Cancer | NIH | National Cancer Institute | 2021 | $661,095 | April 1, 2021 | August 31, 2021 | BRENTJENS, RENIER JOSEPH | reporter.nih.gov |
| Imaging tumor and T cell responses to metabolic and immune modulation therapy | NIH | National Cancer Institute | 2021 | $650,075 | June 20, 2017 | September 15, 2022 | MERGHOUB, TAHA | reporter.nih.gov |
| Schwann Cell Reprogramming and Cancer Perineural Invasion | NIH | National Cancer Institute | 2021 | $640,689 | August 1, 2017 | July 31, 2022 | WONG, RICHARD J | reporter.nih.gov |
| MSK Immuno-Oncology for the Translational Researcher Short Course | NIH | National Cancer Institute | 2021 to 2022 | $640,234 | April 1, 2020 | March 31, 2024 | NEILL, USHMA | reporter.nih.gov |
| Uncovering Roles of Metabolites in Colorectal Cancer Etiology | NIH | National Cancer Institute | 2021 to 2022 | $639,201 | August 1, 2020 | June 30, 2024 | SHU, XIANG | reporter.nih.gov |
| Isoquercetin as a PDI inhibitor: dose-optimization and patient phenotyping | NIH | National Center for Complementary & Integrative Health | 2025 | $631,382 | April 15, 2025 | January 31, 2030 | ZWICKER, JEFFREY | reporter.nih.gov |
| Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition | NIH | National Cancer Institute | 2021 | $628,810 | May 18, 2018 | April 30, 2023 | DRILON, ALEXANDER | reporter.nih.gov |
| Protein and proteolytic activity biomarkers of early stage pancreatic cancer | NIH | National Cancer Institute | 2021 | $623,472 | March 3, 2017 | February 28, 2023 | TEMPST, PAUL | reporter.nih.gov |
| Quantitative imaging tools to derive DW-MRI oncological biomarkers | NIH | National Cancer Institute | 2021 | $619,983 | July 1, 2017 | June 30, 2023 | DAVE, AMITA | reporter.nih.gov |
| Exploiting alpha-ketoglutarate-dependent metabolism for therapeutic benefit in acute myeloid leukemia | NIH | National Cancer Institute | 2022 to 2024 | $618,228 | August 17, 2022 | July 31, 2027 | MILLMAN, SCOTT EVAN | reporter.nih.gov |
| Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy | NIH | National Cancer Institute | 2021 | $614,801 | September 30, 2017 | August 31, 2022 | BALACHANDRAN, VINOD P | reporter.nih.gov |
| Mechanisms of energy storage in lipid droplets | NIH | National Institute of General Medical Sciences | 2025 | $609,493 | June 1, 2025 | May 31, 2030 | FARESE, ROBERT V | reporter.nih.gov |
| Understanding mechanisms of impaired immunity in the AML bone marrow | NIH | National Cancer Institute | 2024 to 2025 | $607,242 | July 1, 2024 | June 30, 2029 | DEWOLF, SUSAN E | reporter.nih.gov |
| Role of Fc Receptors in the Therapeutic Activity of Antibodies Targeting the CD47-SIRP-alpha axis | NIH | National Cancer Institute | 2022 to 2025 | $605,356 | September 1, 2022 | August 31, 2027 | OSORIO, JUAN C | reporter.nih.gov |
| The X-Rad SmART+ Biological Irradiator for Pre-Clinical Oncology Research | NIH | Office of the Director, National Institutes of Health | 2021 | $600,000 | September 17, 2021 | September 16, 2022 | ZANZONICO, PAT B | reporter.nih.gov |
| Bruker AV-NEO Console for 7T MRI | NIH | Office of the Director, National Institutes of Health | 2022 | $600,000 | September 1, 2022 | August 31, 2023 | LEKAYE, HONGBIAO CARL | reporter.nih.gov |
| Anti-ceramide Ab Preserves Intestinal Stem Cells and Prevents GI-ARS and GI-DEARE | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $597,518 | December 2, 2024 | November 30, 2029 | KOLESNICK, RICHARD N | reporter.nih.gov |
| Defining the Role of Developmental Context in Oncohistone-Driven Gliomagenesis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $586,768 | August 15, 2022 | May 31, 2027 | GRAHAM, MAYA SRIKANTH | reporter.nih.gov |
| The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response | NIH | National Cancer Institute | 2025 | $583,973 | January 1, 2025 | December 31, 2029 | SOLIT, DAVID B. | reporter.nih.gov |
| Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $583,790 | August 1, 2017 | July 31, 2022 | KOLESNICK, RICHARD N | reporter.nih.gov |
| Investigating the role of Microhomology-Mediated End-Joining (MMEJ) in Mitosis and its impact on drug resistance | NIH | National Cancer Institute | 2025 | $581,381 | June 5, 2025 | May 31, 2030 | SFEIR, AGNEL | reporter.nih.gov |
| Understanding human pancreas development for diabetes cell-replacement therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $570,128 | July 1, 2012 | July 31, 2023 | HUANGFU, DANWEI | reporter.nih.gov |
| Regulation of Nfil3 in innate lymphocyte-mediated host immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $567,610 | April 1, 2017 | March 31, 2022 | SUN, JOSEPH CHAI-YUEN | reporter.nih.gov |
| Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer | NIH | National Cancer Institute | 2022 | $566,084 | June 1, 2018 | May 31, 2024 | SCHWARTZ, LAWRENCE H | reporter.nih.gov |
| Quantitative Sciences Summer Undergraduate Research Experience (QSURE) | NIH | National Cancer Institute | 2021 to 2025 | $559,902 | December 1, 2017 | November 30, 2028 | BEGG, COLIN B | reporter.nih.gov |
| Dynamics of Primary Cilia Formation During Mammalian Development | NIH | National Institute of General Medical Sciences | 2021 | $551,977 | January 1, 2018 | November 30, 2022 | JOYNER, ALEXANDRA L. | reporter.nih.gov |
| Developing therapeutic TCR mimic monoclonal antibodies for cancer | NIH | National Cancer Institute | 2022 to 2025 | $540,804 | September 1, 2022 | August 31, 2027 | DAO, TAO | reporter.nih.gov |
| Molecular mechanisms of protein function | NIH | National Institute of General Medical Sciences | 2025 | $534,160 | June 1, 2025 | May 31, 2030 | HITE, RICHARD KEVIN | reporter.nih.gov |
| Decoding disease-critical genomic architecture using multimodal single-cell omics data | NIH | National Human Genome Research Institute | 2025 | $522,866 | May 1, 2025 | April 30, 2030 | DEY, KUSHAL KUMAR | reporter.nih.gov |
| Exploiting ferroportin for cancer imaging and therapy | NIH | National Cancer Institute | 2021 | $521,740 | June 9, 2017 | May 30, 2022 | GRIMM, JAN | reporter.nih.gov |
| Microbiota mechanisms and biomarkers in GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $514,836 | April 1, 2019 | March 31, 2024 | PELED, JONATHAN | reporter.nih.gov |
| Role of lymphatic endothelial cell NFkB signaling in adult lymph node homeostasis | NIH | National Institute on Aging | 2024 | $513,957 | September 1, 2024 | August 31, 2026 | KATARU, RAGHU PRASAD | reporter.nih.gov |
| Investigating L1CAM-dependent stem cell regeneration in metastasis | NIH | National Cancer Institute | 2021 to 2022 | $513,638 | August 13, 2018 | July 31, 2023 | GANESH, KARUNA | reporter.nih.gov |
| Targeting replication stress signaling to overcome immune evasion in small cell lung cancer | NIH | National Cancer Institute | 2021 | $513,261 | April 1, 2021 | May 31, 2022 | SEN, TRIPARNA | reporter.nih.gov |
| Automatic integrated biomarkers to improve prediction of lung cancer outcomes | NIH | National Cancer Institute | 2024 to 2025 | $512,974 | August 13, 2024 | July 31, 2029 | JEE, JUSTIN | reporter.nih.gov |
| Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) | NIH | National Cancer Institute | 2023 to 2024 | $501,023 | September 1, 2023 | August 31, 2028 | SANDS, STEPHEN ALAN | reporter.nih.gov |
| Collaborative Research: Illumination of Smc5/6 management of DNA repair intermediate structures | NSF | Molecular Biosciences | 2024 | $500,000 | July 1, 2024 | June 30, 2027 | Xiaolan Zhao | nsf.gov |
| Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance | NIH | National Cancer Institute | 2021 | $499,575 | August 1, 2017 | July 31, 2023 | CHEN, YU | reporter.nih.gov |
| Molecular recording to understand the determinants of cell fate transitions in early development | NIH | National Human Genome Research Institute | 2024 to 2025 | $498,000 | March 15, 2024 | February 28, 2027 | CHOI, JUNHONG | reporter.nih.gov |
| Role of Mast cells in regulating inflammatory pathology of secondary lymphedema | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $497,136 | July 23, 2025 | June 30, 2027 | KATARU, RAGHU PRASAD | reporter.nih.gov |
| Evaluation and Development of Statistical Methods for Data Harmonization in Molecular Prognostication | NIH | National Human Genome Research Institute | 2021 | $496,342 | September 3, 2021 | February 28, 2025 | QIN, LI-XUAN | reporter.nih.gov |
| Deciphering pathogenesis and therapeutic vulnerabilities in germline RUNX1 mutated AML | NIH | National Cancer Institute | 2025 | $495,715 | August 5, 2025 | July 31, 2030 | XIAO, WENBIN | reporter.nih.gov |
| Regulation of Chromosome Segregation in Human Cells | NIH | National Institute of General Medical Sciences | 2021 | $489,753 | July 1, 2005 | May 31, 2024 | JALLEPALLI, PRASAD V | reporter.nih.gov |
| Leveraging Medicare Linkages to Identify New Associations: Prescription Drugs and Digestive Cancer Risk | NIH | National Cancer Institute | 2022 | $488,048 | September 22, 2022 | August 31, 2025 | DU, MENGMENG | reporter.nih.gov |
| Backup DNA repair in homologous recombination deficient cancers | NIH | National Cancer Institute | 2025 | $487,393 | December 1, 2024 | November 30, 2029 | POWELL, SIMON N. | reporter.nih.gov |
| Functional analysis of the immune landscape in IDH mutant gliomas | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $486,750 | April 15, 2021 | September 30, 2023 | TABAR, VIVIANE | reporter.nih.gov |
| The mycobiota, bone marrow transplantation, and clinical outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $486,750 | June 1, 2021 | May 31, 2024 | HOHL, TOBIAS M | reporter.nih.gov |
| Scalable, quantitative, single-cell CRISPR screens | NIH | National Human Genome Research Institute | 2022 to 2023 | $486,750 | August 1, 2022 | July 31, 2024 | NORMAN, THOMAS MAXWELL | reporter.nih.gov |
| Architectural regulation of cytotoxic synapse detachment | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $486,750 | March 1, 2022 | February 29, 2024 | HUSE, MORGAN A | reporter.nih.gov |
| Molecular mechanisms of age-related lymphatic dysfunction | NIH | National Institute on Aging | 2022 to 2023 | $486,750 | July 15, 2022 | March 31, 2025 | MEHRARA, BABAK J | reporter.nih.gov |
| Targeting the alpha secretase ADAM10 for the treatment of Alzheimer's disease | NIH | National Institute on Aging | 2023 to 2024 | $486,750 | December 1, 2022 | November 30, 2025 | NIKOLOV, DIMITAR B | reporter.nih.gov |
| Molecular and cellular pathways driving competency for human vagal neural crest specification | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $486,750 | September 19, 2023 | August 31, 2025 | STUDER, LORENZ P. | reporter.nih.gov |
| Recombinase polymerase amplification to enable same-cell, DNA/RNA multi-omic single cell sequencing | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $486,750 | January 1, 2024 | June 30, 2026 | HIGGINSON, DANIEL | reporter.nih.gov |
| Studies on Lineage Plasticity in Prostate Cancer | NIH | National Cancer Institute | 2023 to 2024 | $483,675 | July 1, 2023 | March 3, 2025 | ZAIDI, SAMIR | reporter.nih.gov |
| Targeting the Epidermal Growth Factor Receptor (EGFR) to Revert Trastuzumab Deruxtecan Resistance in HER2-low Colorectal Cancer. | NIH | National Cancer Institute | 2025 | $482,236 | August 1, 2025 | July 31, 2030 | YAEGER, RONA | reporter.nih.gov |
| A Pragmatic Randomized Control Trial of Nurse-Delivered Brief Meaning Centered Psychotherapy for Homebound Palliative Care Patients | NIH | National Institute of Nursing Research | 2021 to 2022 | $476,458 | September 1, 2021 | July 31, 2025 | SARACINO, REBECCA | reporter.nih.gov |
| Advanced planar image reconstruction for targeted alpha therapy | NIH | National Cancer Institute | 2022 to 2023 | $473,658 | April 1, 2022 | March 31, 2025 | SCHMIDTLEIN, CHARLES ROSS | reporter.nih.gov |
| Clinical assessment of radiotherapy-induced vaginal toxicity with multiparametric ultrasound imaging | NIH | National Cancer Institute | 2024 to 2025 | $468,786 | September 1, 2024 | August 31, 2026 | BURGESS, MARK THOMAS | reporter.nih.gov |
| Communicating the Gist of Prognosis: An intervention to improve prognostic understanding in advanced lymphoma | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2023 | $465,650 | September 25, 2022 | June 30, 2025 | MCCONNELL, KELLY | reporter.nih.gov |
| Genomics of Renal Cancer in Patients of African Ancestry | NIH | National Cancer Institute | 2023 to 2024 | $456,248 | May 2, 2023 | April 30, 2025 | ZHANG, JIAN | reporter.nih.gov |
| Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life | NIH | National Cancer Institute | 2023 to 2025 | $455,112 | August 1, 2023 | June 30, 2026 | FLORY, JAMES H | reporter.nih.gov |
| Leveraging the Hidden Genome to Recover the Missing Heritability of Cancer | NIH | National Cancer Institute | 2023 | $455,111 | September 5, 2023 | August 31, 2025 | SHEN, RONGLAI | reporter.nih.gov |
| eDyNAmiC (extrachromosomal DNA in Cancer) - Understanding the biology of ecDNA generation and action, and developing new ways to target these mechanisms in cancer | NIH | National Cancer Institute | 2024 to 2025 | $454,946 | June 1, 2024 | May 31, 2026 | VENTURA, ANDREA | reporter.nih.gov |
| Electronic Nose Technology to Predict and Assess Pathologic Response After Neoadjuvant Therapy and Recurrence for Non-Small Cell Lung Cancer | NIH | National Cancer Institute | 2025 | $452,540 | July 1, 2025 | June 30, 2027 | ROCCO, GAETANO | reporter.nih.gov |
| Bispecific antibodies in multiple myeloma: understanding therapy resistance through imaging | NIH | National Cancer Institute | 2025 | $452,540 | July 11, 2025 | June 30, 2027 | PONOMAREV, VLADIMIR | reporter.nih.gov |
| Neoadjuvant PD-1 blockade in mismatch repair deficient rectal cancer | NIH | National Cancer Institute | 2021 to 2022 | $450,975 | February 1, 2021 | January 31, 2024 | CERCEK, ANDREA | reporter.nih.gov |
| Investigation of the impact of pegylated Interferon on clonal trajectory and inflammatory cytokine production in MPN patients | NIH | National Cancer Institute | 2022 to 2023 | $450,975 | December 1, 2021 | November 30, 2024 | RAMPAL, RAAJIT | reporter.nih.gov |
| Dopamine Metabolism and Nonpharmacologic Insomnia Interventions Among Cancer Survivors | NIH | National Cancer Institute | 2022 to 2023 | $450,975 | July 1, 2022 | June 30, 2025 | MAO, JUN J | reporter.nih.gov |
| Patient-derived organoids reveal rectal cancers develop radiosensitivity | NIH | National Cancer Institute | 2021 to 2022 | $450,147 | February 5, 2021 | January 31, 2024 | KOLESNICK, RICHARD N | reporter.nih.gov |
| Programming age in iPS models of Alzheimer's disease | NIH | National Institute on Aging | 2021 | $449,000 | July 15, 2017 | March 31, 2022 | STUDER, LORENZ P. | reporter.nih.gov |
| Investigating long noncoding RNAs as regulators of the p53 pathway functions. | NIH | National Institute of General Medical Sciences | 2021 | $449,000 | August 1, 2017 | July 31, 2022 | SCHMITT, ADAM | reporter.nih.gov |
| Enhancing Health Cost Literacy and Financial Capability among Young Adult Cancer Survivors | NIH | National Cancer Institute | 2022 to 2023 | $447,810 | April 11, 2022 | March 31, 2025 | FRIEDMAN, DANIELLE | reporter.nih.gov |
| Molecular biomarkers of future aggressive behavior in pituitary tumors | NIH | National Cancer Institute | 2023 to 2024 | $444,768 | April 15, 2023 | March 31, 2026 | LIN, ANDREW | reporter.nih.gov |
| Control of Intestinal Epithelial Function through Lymphatic-Intestinal Stem Cell Communication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $442,493 | April 1, 2023 | February 28, 2026 | NIEC, RACHEL E | reporter.nih.gov |
| Decoding the Ubiquitin and Autophagy Signaling Networks | NIH | National Institute of General Medical Sciences | 2025 | $440,000 | February 3, 2025 | December 31, 2029 | ORDUREAU, ALBAN | reporter.nih.gov |
| Mechanisms of Lipid Droplet Protein Targeting | NIH | National Institute of General Medical Sciences | 2025 | $440,000 | August 1, 2025 | May 31, 2030 | WALTHER, TOBIAS C | reporter.nih.gov |
| Ultra-stable, photon-efficient cryogenic super-resolution fluorescence imaging for visualizing vitrified biological samples with molecular-scale resolution | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $437,075 | September 20, 2022 | August 31, 2025 | PERTSINIDIS, ALEXANDROS | reporter.nih.gov |
| A telehealth intervention to improve initiation of mental health treatment among depressed older adults with cancer | NIH | National Cancer Institute | 2022 | $435,559 | September 20, 2022 | August 31, 2025 | MCCONNELL, KELLY | reporter.nih.gov |
| Incidental diagnosis of clonal hematopoiesis among healthy, unrelated, hematopoietic stem cell donors: A feasibility study of psychosocial, ethical, and clinical issues | NIH | National Cancer Institute | 2024 | $433,895 | July 2, 2024 | June 30, 2026 | TAMARI, RONI | reporter.nih.gov |
| Role of epidermis in regulating inflammatory skin manifestations of post-surgical lymphedema | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $422,499 | December 21, 2022 | November 30, 2024 | MEHRARA, BABAK J | reporter.nih.gov |
| Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening | NIH | National Cancer Institute | 2021 to 2022 | $421,787 | September 25, 2018 | September 30, 2022 | CARTER-BAWA, LISA | reporter.nih.gov |
| Integrating Electronic Patient-Reported Outcomes into Discharge Planning | NIH | National Cancer Institute | 2024 to 2025 | $420,028 | July 1, 2024 | June 30, 2029 | CRACCHIOLO, JENNIFER R | reporter.nih.gov |
| Programmable nucleic acid cytometry for unraveling heterogeneity in tumors and therapies | NIH | National Cancer Institute | 2025 | $418,176 | September 1, 2025 | August 31, 2028 | LAREAU, CALEB ANDREW | reporter.nih.gov |
| Cellular Origins, Molecular Pathogenesis, and Novel Therapeutic Strategies for MAP Kinase-Driven Hematological Malignancies | NIH | National Cancer Institute | 2021 to 2022 | $417,330 | March 13, 2018 | February 29, 2024 | DURHAM, BENJAMIN HEATH | reporter.nih.gov |
| Therapeutic approaches to ER mutant breast cancer | NIH | National Cancer Institute | 2021 | $410,835 | January 1, 2017 | December 31, 2022 | CHANDARLAPATY, SARAT | reporter.nih.gov |
| Understanding Long Tail Driver Mutations in Cancer | NIH | National Cancer Institute | 2021 | $410,835 | February 6, 2017 | January 31, 2022 | SCHULTZ, NIKOLAUS | reporter.nih.gov |
| Reducing the chasm in behavioral health care for older adults with cancer: Development of the Center for Implementation Research in Cancer in Later Life (CIRCL) | NIH | National Cancer Institute | 2023 to 2024 | $407,038 | August 1, 2023 | July 31, 2025 | MCCONNELL, KELLY | reporter.nih.gov |
| Biomechanical control of inflammation by the nuclear membrane | NIH | National Institute of General Medical Sciences | 2021 | $404,100 | May 1, 2018 | February 28, 2022 | NIETHAMMER, PHILIPP MICHAEL | reporter.nih.gov |
| Pilot Feasibility of DESCANSO: Cognitive Behavioral Therapy for Latino Cancer Patients to Treat the Symptom Cluster Depression, Insomnia and Fatigue | NIH | National Cancer Institute | 2025 | $403,822 | August 13, 2025 | July 31, 2030 | COSTAS-MUNIZ, ROSARIO | reporter.nih.gov |
| Development of chimeric antigen receptor T cells targeting cell surface U5 snRNP for the treatment of acute myeloid leukemia | NIH | National Cancer Institute | 2025 | $402,600 | April 3, 2025 | March 31, 2030 | DANIYAN, ANTHONY FOLAWUYI | reporter.nih.gov |
| Assessment of Tim-4+ Pleural Macrophages as Negative Regulators of Anti-Tumor T Cell Immunity in Lung Cancer | NIH | National Cancer Institute | 2021 to 2022 | $401,150 | July 1, 2020 | June 30, 2023 | CHOW, ANDREW | reporter.nih.gov |
| The Rtt107 interactome structures and functions | NIH | National Institute of General Medical Sciences | 2021 | $395,120 | September 20, 2007 | December 31, 2022 | ZHAO, XIAOLAN | reporter.nih.gov |
| Investigating the Role of Cell Plasticity in Malignant Transformation | NIH | National Cancer Institute | 2022 to 2025 | $388,899 | April 1, 2022 | March 31, 2026 | CHAIKOVSKY, ANDREA CHRISTINE | reporter.nih.gov |
| Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery | NIH | National Cancer Institute | 2021 | $388,526 | December 1, 2015 | November 30, 2023 | NELSON, CHRISTIAN J | reporter.nih.gov |
| Investigating the functions of the miR-17~92 family of oncogenic microRNA clusters | NIH | National Cancer Institute | 2021 | $385,650 | April 1, 2010 | November 30, 2022 | VENTURA, ANDREA | reporter.nih.gov |
| Immunology Research Training | NIH | National Cancer Institute | 2021 to 2022 | $382,028 | July 1, 1976 | December 31, 2023 | RUDENSKY, ALEXANDER Y | reporter.nih.gov |
| Adaptation and Pilot Feasibility of a Psychotherapy Intervention for Latinos with Advanced Cancer | NIH | National Cancer Institute | 2021 to 2022 | $360,622 | September 13, 2018 | August 31, 2025 | COSTAS-MUNIZ, ROSARIO | reporter.nih.gov |
| The role of reorganization energy in achieving selective kinase inhibition | NIH | National Institute of General Medical Sciences | 2021 | $352,465 | September 15, 2017 | August 31, 2022 | CHODERA, JOHN DAMON | reporter.nih.gov |
| Mobile phone-based deep learning algorithm for oral lesion screening in low-resource settings | NIH | National Cancer Institute | 2023 to 2024 | $351,680 | June 7, 2023 | May 31, 2025 | RAJADHYAKSHA, MILIND | reporter.nih.gov |
| Mechanisms and vulnerabilities of ERG-driven luminal fate in prostate cancer | NIH | National Cancer Institute | 2023 to 2024 | $346,032 | April 1, 2023 | January 31, 2025 | FENG, WEIRAN | reporter.nih.gov |
| The role of the novel interface cell state in melanoma invasion | NIH | National Cancer Institute | 2023 to 2024 | $346,032 | April 1, 2023 | March 31, 2026 | HUNTER, MIRANDA VICTORIA | reporter.nih.gov |
| Dissecting FOSL1-mediated lineage plasticity and resistance to androgen receptor signaling inhibition in prostate cancer | NIH | National Cancer Institute | 2024 to 2025 | $346,032 | June 1, 2024 | May 31, 2027 | WONG, CHEN KHUAN | reporter.nih.gov |
| Genomics Research Experience for Master's Students (GEMS) Fellowship | NIH | National Cancer Institute | 2023 to 2025 | $341,649 | April 1, 2023 | March 31, 2028 | PANAGEAS, KATHERINE S | reporter.nih.gov |
| Molecular control of tissue morphogenesis | NIH | National Institute of General Medical Sciences | 2021 | $337,197 | September 1, 2007 | July 31, 2023 | ZALLEN, JENNIFER A | reporter.nih.gov |
| Dissecting the role of clonal evolution in NPM1-mutant AML | NIH | National Cancer Institute | 2021 to 2022 | $336,528 | April 1, 2021 | August 14, 2022 | MILES, LINDE A | reporter.nih.gov |
| Mobile phone-based deep learning algorithm for oral lesion screening in low-resource settings | NIH | National Cancer Institute | 2025 | $331,721 | June 7, 2023 | May 31, 2028 | RAJADHYAKSHA, MILIND | reporter.nih.gov |
| Systems biology of the tumor immune microenvironment | NIH | National Cancer Institute | 2021 | $330,912 | August 1, 2021 | July 31, 2022 | LESLIE, CHRISTINA S | reporter.nih.gov |
| Arylepoxamides: A new class of potent, safer analgesics | NIH | National Institute on Drug Abuse | 2021 | $329,534 | December 15, 2020 | July 31, 2021 | PAN, YING-XIAN | reporter.nih.gov |
| Head and Neck Training Program in Surgical Oncology | NIH | National Cancer Institute | 2021 to 2022 | $322,197 | July 1, 2019 | June 30, 2024 | WONG, RICHARD J | reporter.nih.gov |
| The role of the intestinal microbiome in cancer immunotherapy | NIH | National Cancer Institute | 2023 | $303,632 | August 1, 2023 | October 16, 2023 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $371,000 |
| 2025 | 311 | $239,211,076 | 2 | $443,312 |
| 2024 | 332 | $203,600,856 | 2 | $219,688 |
| 2023 | 342 | $201,116,397 | 1 | $147,000 |
| 2022 | 335 | $269,487,687 | 1 | $240,084 |
| 2021 | 312 | $186,761,493 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-27-089 | NIH | 93.398 | November 2, 2026 | Not listed | Same assistance listing 93.398 as 101 awards here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.398 | November 20, 2026 | Not listed | Same assistance listing 93.398 as 101 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.398 | December 3, 2026 | Not listed | Same assistance listing 93.398 as 101 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.398 | December 3, 2026 | Not listed | Same assistance listing 93.398 as 101 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.398 | December 4, 2026 | Not listed | Same assistance listing 93.398 as 101 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.398 | February 11, 2027 | $775,000 | Same assistance listing 93.398 as 101 awards here |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) | RFA-OD-25-003 | NIH | 93.398 | April 9, 2027 | $200,000 | Same assistance listing 93.398 as 101 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) | PA-24-190 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) | PA-24-191 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) | PA-24-193 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | 93.398 | May 7, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) | PA-24-181 | NIH | 93.398 | May 8, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | PA-24-253 | NIH | 93.398 | July 17, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| Investigator-Focused Award (Parent R35) | PAR-28-037 | NIH | 93.398 | October 4, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) | PAR-25-135 | NIH | 93.398 | October 14, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) | PAR-25-313 | NIH | 93.398 | October 14, 2027 | Not listed | Same assistance listing 93.398 as 101 awards here |
Topics of its NIH awards
- Cancer
- Genetics
- Clinical Research
- Rare Diseases
- Biotechnology
- Human Genome
- Cancer Genomics
- Immunotherapy
- Translational Research
- Prevention
- Digestive Diseases
- Bioengineering
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.